Category,FY,Funding IC,Project Number,Sub Project #,Project Title,PI Name,Org Name,State / Country,Amount
Lymphoma,2014,NIAID,5R01AI083453-05,,The NF-kB signaling system as a regulator of B-cell activation,"HOFFMANN, ALEXANDER",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$40,878"
Lymphoma,2014,NCI,5R01CA085180-13,,Epstein-Barr Virus LMP1-Mediated Oncogenecity,"KIEFF, ELLIOTT",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$680,363"
Lymphoma,2014,NCI,5R01CA134674-05,,GENETIC EPIDEMIOLOGY OF CHRONIC LYMPHOCYTIC LEUKEMIA,"CAMP, NICOLA",UNIVERSITY OF UTAH,UT,"$509,782"
Lymphoma,2014,NCI,5R01CA117830-09,,Regulation of KSHV Latency,"LIEBERMAN, PAUL",WISTAR INSTITUTE,PA,"$309,287"
Lymphoma,2014,NCI,5R01CA139319-05,,The ARF Tumor Suppressor,"MURPHY, MAUREEN",WISTAR INSTITUTE,PA,"$361,188"
Lymphoma,2014,NCI,5R01CA102184-09,,Functional Analysis of p53 Polymorphic Variants,"MURPHY, MAUREEN",WISTAR INSTITUTE,PA,"$335,745"
Lymphoma,2014,NCI,5R01CA138891-05,,In vivo targeting of hematopoetic cells with glycan ligands of siglecs,"PAULSON, JAMES",SCRIPPS RESEARCH INSTITUTE,CA,"$365,448"
Lymphoma,2014,NCI,5R01CA142809-05,,Signal Transduction Pathways in CD30-positive Lymphomas,"DUCKETT, COLIN",UNIVERSITY OF MICHIGAN,MI,"$300,886"
Lymphoma,2014,NCI,5R01CA095318-10,,Role of B Cells in Murine Gammaherpesvirus-68 Latency,"SPECK, SAMUEL",EMORY UNIVERSITY,GA,"$320,872"
Lymphoma,2014,NCI,5R01CA104588-10,,RAG-induced DNA damage: mechanisms and responses,"ROTH, DAVID",UNIVERSITY OF PENNSYLVANIA,PA,"$266,568"
Lymphoma,2014,NCI,5R01CA080320-15,,Myc Oncogene Mutations and Polymorphisms in Cancer,"COLE, MICHAEL",DARTMOUTH COLLEGE,NH,"$326,672"
Lymphoma,2014,NCI,5P30CA016520-38,5516,Tumor Virology Program,"LERMAN, CARYN",UNIVERSITY OF PENNSYLVANIA,PA,"$115,256"
Lymphoma,2014,NCI,5P30CA016520-38,5520,Melanoma and Cutaneous Malignancies Program,"LERMAN, CARYN",UNIVERSITY OF PENNSYLVANIA,PA,"$115,856"
Lymphoma,2014,NCI,5P30CA016520-38,5521,Hematologic Malignancies Program,"LERMAN, CARYN",UNIVERSITY OF PENNSYLVANIA,PA,"$135,765"
Lymphoma,2014,NCI,5P30CA016086-38,8689,Virology,"TRAUB, N",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$133,482"
Lymphoma,2014,NCI,5P30CA016086-38,8690,Virology,"TRAUB, N",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$142,314"
Lymphoma,2014,NCI,5R01CA138747-05,,microRNA-155 and Lymphoma,"AGUIAR, RICARDO",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$289,927"
Lymphoma,2014,NCI,5R01CA142798-05,,The contribution of protein translation to tumorigenesis,"WENDEL, HANS-GUIDO",SLOAN-KETTERING INST CAN RESEARCH,NY,"$370,951"
Lymphoma,2014,NCI,5R21CA171937-02,,Inhibitory targeting of HHV-8 vIL-6-related interactions.,"NICHOLAS, JOHN",JOHNS HOPKINS UNIVERSITY,MD,"$205,068"
Lymphoma,2014,NCI,5R01CA114536-10,,Strategies to improve the adoptive transfer of T cells,"RIDDELL, STANLEY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$448,945"
Lymphoma,2014,NCI,5R01CA154739-03,,Targeting Slc16a/Mct Lactate Transporters in Cancer Therapeutics,"CLEVELAND, JOHN",SCRIPPS FLORIDA,FL,"$747,603"
Lymphoma,2014,NCI,5R01CA148950-04,,Regulation of Myc-Mediated Tumorigenesis,"EISCHEN, CHRISTINE",VANDERBILT UNIVERSITY,TN,"$313,718"
Lymphoma,2014,NIEHS,5R01ES010807-14,,Molecular Mechanisms of Complex Mixture Toxicity,"PUGA, ALVARO",UNIVERSITY OF CINCINNATI,OH,"$447,496"
Lymphoma,2014,NCI,5R01CA142664-05,,Engineered tumor-specific T cells Resist Hypoxic-Tumor Immunosuppressive Attacks.,"YOTNDA, PATRICIA",BAYLOR COLLEGE OF MEDICINE,TX,"$299,690"
Lymphoma,2014,NCI,5R01CA172492-02,,Role of MLL2 Gene Inactivation in B cell Non Hodgkin Lymphoma,"PASQUALUCCI, LAURA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$322,040"
Lymphoma,2014,NCI,5R01CA166450-02,,Characterizing tumor suppressive functions of microRNAs in B-cell neoplasia,"RAO, DINESH",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$309,964"
Lymphoma,2014,NCI,5R03CA167752-02,,Alternative Cleavage and Polyadenylation Events as Biomarkers,"WAGNER, ERIC",UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,TX,"$73,720"
Lymphoma,2014,NCI,5R37CA084628-22,,"Telomerase in Development, Senescence and Neoplasia","DEPINHO, RONALD",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$600,026"
Lymphoma,2014,NCI,5R01CA172582-02,,Alpha Radioimmunotherapy for Lymphoma Treatment,"SANDMAIER, BRENDA",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$640,365"
Lymphoma,2014,NIAID,5R00AI099153-03,,Regulation of EBV Latency by Chromosome Conformation,"TEMPERA, ITALO",TEMPLE UNIV OF THE COMMONWEALTH,PA,"$249,000"
Lymphoma,2014,NCI,5R01CA164178-02,,A novel NKG2D-specific BiTE cancer immunotherapy,"SENTMAN, CHARLES",DARTMOUTH COLLEGE,NH,"$326,066"
Lymphoma,2014,NIAID,5R01AI106393-02,,BH3-only protein targeting by HHV-8,"NICHOLAS, JOHN",JOHNS HOPKINS UNIVERSITY,MD,"$405,000"
Lymphoma,2014,NCI,5P30CA006516-49,6047,Lymphoma and Myeloma,"SHIPP, MARGARET",DANA-FARBER CANCER INST,MA,"$88,354"
Lymphoma,2014,NCI,5R01CA143032-05,,Molecular Targeting of Diffuse Large B-cell Lymphoma,"MELNICK, ARI",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$502,192"
Lymphoma,2014,NCI,5R01CA165206-03,,CD19 Directed CAR Therapy,"JUNE, CARL",UNIVERSITY OF PENNSYLVANIA,PA,"$489,347"
Lymphoma,2014,NCI,5R01CA138541-05,,Myxoma Virus (MV) Oncolysis for treating human cancer,"MCFADDEN, GRANT",UNIVERSITY OF FLORIDA,FL,"$286,022"
Lymphoma,2014,NHLBI,5R01HL116452-02,,The role of the SF3B1 splicing factor in chronic lymphocytic leukemia,"WU, CATHERINE",DANA-FARBER CANCER INST,MA,"$425,929"
Lymphoma,2014,NIAID,5R21AI103851-02,,Role of HTLV-I Tax-induced NF-kB in activation of ICN1 and immortalization of vir,"NICOT, CHRISTOPHE",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$226,500"
Lymphoma,2014,NCI,5R01CA158073-04,,The Role of ATM in Suppression of Lymphomas,"ZHA, SHAN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$322,040"
Lymphoma,2014,NCI,5R01CA155226-04,,Targeting the heat shock response for the therapy of DLBCL,"MELNICK, ARI",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$481,623"
Lymphoma,2014,NCI,5R01CA168482-02,,HIV-driven B cell activation: role in the genesis of AIDS-related lymphoma,"MARTINEZ-MAZA, OTONIEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$309,964"
Lymphoma,2014,NIAID,5U01AI104342-02,,Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children,"ESQUIVEL, CARLOS",STANFORD UNIVERSITY,CA,"$1,363,549"
Lymphoma,2014,NCI,5R01CA088763-13,,LANA and Cellular Gene Expression,"RENNE, ROLF",UNIVERSITY OF FLORIDA,FL,"$224,007"
Lymphoma,2014,NCI,5R01CA153260-15,,Control of Lineage Commitment in Developing Thymocytes,"KAPPES, DIETMAR",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$435,886"
Lymphoma,2014,NCI,5R01CA154228-04,,Targeting vFLIP for the treatment of KSHV-associated malignancies,"CESARMAN, ETHEL",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$340,155"
Lymphoma,2014,NCI,5R01CA166144-03,,Development of Therapeutic CD59 inhibitor for treating B-cell malignancies,"QIN, XUEBIN",TEMPLE UNIV OF THE COMMONWEALTH,PA,"$324,825"
Lymphoma,2014,NCI,5R01CA140963-05,,Cell Cycle Regulation and Adult T Cell Leukemia,"GIAM, CHOU-ZEN",HENRY M. JACKSON FDN FOR THE ADV MIL/MED,MD,"$298,713"
Lymphoma,2014,NCI,5R01CA164605-03,,Hdac3 as a therapeutic target in BCL6-dependent lymphoma,"HIEBERT, SCOTT",VANDERBILT UNIVERSITY,TN,"$391,041"
Lymphoma,2014,NCI,5R01CA149707-05,,Investigating the functions of the miR-17~92 family of oncogenic microRNA cluster,"VENTURA, ANDREA",SLOAN-KETTERING INST CAN RESEARCH,NY,"$372,707"
Lymphoma,2014,NCI,5R01CA133571-05,,Coordinately regulated alternative splicing in DNA damage and cancer,"CHANDLER, DAWN",RESEARCH INST NATIONWIDE CHILDREN'S HOSP,OH,"$289,653"
Lymphoma,2014,NCI,1P01CA174653-01A1,6841,The Role of CTIP in Lymphocyte Development and Lymphomagenesis,"ZHA, SHAN",COLUMBIA UNIVERSITY,NY,"$364,328"
Lymphoma,2014,NCI,1P01CA174653-01A1,6845,Pathology,"BHAGAT, GOVIND",COLUMBIA UNIVERSITY,NY,"$188,901"
Lymphoma,2014,NCI,5R00CA154889-04,,Mechanisms of subtelomere recombination in telomerase deficient tumors,"MORRISH, TAMMY",UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS,OH,"$134,115"
Lymphoma,2014,NCI,5R01CA068051-19,,Pathogenesis of EBV Infection,"WANG, FREDERICK",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$435,089"
Lymphoma,2014,NCI,5R01CA091791-12,,Reactivation of Kaposi's Sarcoma-Associated Herpesvirus,"SUN, REN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$276,011"
Lymphoma,2014,NIBIB,5R01EB012569-04,,Multi-functional Nanocarrier against Canine Lymphoma,"LAM, KIT",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$499,245"
Lymphoma,2014,NIAID,5R01AI018757-32,,Host Immunity to EBV Infection in Vitro and in Vivo,"THORLEY-LAWSON, DAVID",TUFTS UNIVERSITY BOSTON,MA,"$412,500"
Lymphoma,2014,NCI,1R01CA182461-01,,Defining the impact of clonal evolution on chronic lymphocytic leukemia,"WU, CATHERINE",DANA-FARBER CANCER INST,MA,"$362,378"
Lymphoma,2014,NCI,5R01CA157660-03,,The Role of NF-kB in B-Cell Differentiation and Lymphomagenesis,"KLEIN, ULF",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$320,666"
Lymphoma,2014,NCI,5F31CA167917-03,,Elucidating the in vivo Role of the p53 Apoptosis-Specific Target Gene Siva,"FREY, JEANINE",STANFORD UNIVERSITY,CA,"$42,676"
Lymphoma,2014,NCI,5R01CA155143-04,,Predictors of clinical outcome after therapeutic vaccination in follicular lympho,"NEELAPU, SATTVA",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$274,863"
Lymphoma,2014,NCI,5R01CA165469-02,,Role of Tcl1 and Par-4 in regulation of chronic lymphocytic leukemia,"BONDADA, SUBBARAO",UNIVERSITY OF KENTUCKY,KY,"$369,860"
Lymphoma,2014,NCI,5R01CA149254-05,,Antibody-CpG conjugates for the treatment of B cell lymphoma,"TIMMERMAN, JOHN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$300,665"
Lymphoma,2014,NCI,5R01CA068328-18,,Lymph Node Alterations in Cancer,"RUDDELL, M",UNIVERSITY OF WASHINGTON,WA,"$311,887"
Lymphoma,2014,NCI,5R21CA165923-03,,Robust rank-based methods and detection of GXE in cancer etiology and survival,"MA, SHUANGGE",YALE UNIVERSITY,CT,"$140,509"
Lymphoma,2014,NIAID,1R21AI109020-01,,Folliculin Interacting Proteins in Lymphocyte Development and Autoimmunity,"IRITANI, BRIAN",UNIVERSITY OF WASHINGTON,WA,"$193,125"
Lymphoma,2014,NIAID,5R01AI058057-10,,Function of the Gamma HV68 M2 Antigen,"SPECK, SAMUEL",EMORY UNIVERSITY,GA,"$385,800"
Lymphoma,2014,NCI,5R01CA154653-04,,Molecular epidemiology/functional analysis of microRNAs in Non-Hodgkin's lymphoma,"ZHU, YONG",YALE UNIVERSITY,CT,"$335,123"
Lymphoma,2014,NCI,5U54CA112967-10,6516,Migration Networks,"GERTLER, FRANK",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$360,429"
Lymphoma,2014,NCI,5U54CA112967-10,6518,DNA Damage Networks,"YAFFE, MICHAEL",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$301,201"
Lymphoma,2014,NCI,5R01CA119917-07,,Studying the role of KSHV-encoded miRNAs,"RENNE, ROLF",UNIVERSITY OF FLORIDA,FL,"$292,042"
Lymphoma,2014,NCI,5UM1CA173642-02,,Women's Health Initiative Cancer Survivor Cohort,"ANDERSON, GARNET",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$2,232,714"
Lymphoma,2014,NIAID,1R21AI109187-01,,B Cell immunodeficiency in BENTA disease,"SNOW, ANDREW",HENRY M. JACKSON FDN FOR THE ADV MIL/MED,MD,"$226,908"
Lymphoma,2014,NCI,5R01CA174462-02,,New Models and Treatments for AIDS-related Lymphoma,"KENNEY, SHANNON",UNIVERSITY OF WISCONSIN-MADISON,WI,"$404,367"
Lymphoma,2014,NIGMS,1R01GM106067-01A1,,DNA-carbon Assemblies for Multispectral Imaging,"KOOL, ERIC",STANFORD UNIVERSITY,CA,"$300,249"
Lymphoma,2014,NCI,5R21CA176362-02,,Defining molecular biomarkers for CDK4/6-based cancer therapy by RNA sequencing,"CHEN-KIANG, SELINA",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$178,275"
Lymphoma,2014,NCI,5R00CA134743-05,,"""Oncorequisite"" Genes in MYC-mediated Transformation","FENG, HUI",BOSTON UNIVERSITY MEDICAL CAMPUS,MA,"$234,037"
Lymphoma,2014,NCI,5R21CA175461-02,,Role of IRF4-NOTCH2 Interplay in B-Cell Development and Malignancy,"KLEIN, ULF",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$168,781"
Lymphoma,2014,NCI,5F32CA174247-02,,Antagonizing oncogenic microRNAs for the elucidation and treatment of lymphoma,"CHENG, CHRISTOPHER",YALE UNIVERSITY,CT,"$53,282"
Lymphoma,2014,NCI,5R01CA164152-03,,Role of acetyltransferase gene inactivation in follicular lymphoma pathogenesis,"DALLA-FAVERA, RICCARDO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$322,040"
Lymphoma,2014,NCI,5R01CA134807-05,,Targeting Negative Regulatory Pathways for Immunotherapy of B-Cell Lymphomas,"SOTOMAYOR, EDUARDO",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$437,284"
Lymphoma,2014,NCI,5R01CA158323-03,,Studies of Lymphoma Suppression and DNA Repair,"DU, CHUNYING",UNIVERSITY OF CINCINNATI,OH,"$316,002"
Lymphoma,2014,NCI,5F31CA165825-03,,Oncogenic cooperation restrained by a putative internal antagonist in miR-17-92,"SABIO, ERICH",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$25,178"
Lymphoma,2014,NIAID,5R21AI105909-02,,KSHV vaccine development,"JUNG, JAE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$242,548"
Lymphoma,2014,NCI,5U54CA148967-05,6640,Endogenous Heterogeneity of Signaling Pathways in Cancer,"ALTAN-BONNET, GREGOIRE",SLOAN-KETTERING INST CAN RESEARCH,NY,"$446,746"
Lymphoma,2014,NCI,5U54CA149145-05,6610,Center,"PLEVRITIS, SYLVIA",STANFORD UNIVERSITY,CA,"$1,455,018"
Lymphoma,2014,NCI,5U54CA149145-05,6613,MODELING THE ROLE OF PROGRESSION IN FOLLICULAR LYMPHOMA,"LEVY, RONALD",STANFORD UNIVERSITY,CA,"$145,689"
Lymphoma,2014,NCI,5U54CA149145-05,6614,MODELING THE ROLE OF DIFFERENTIATION IN T-ALL,"FELSHER, DEAN",STANFORD UNIVERSITY,CA,"$132,314"
Lymphoma,2014,NCI,5R01CA151748-04,,Genetic Basis of Signaling Heterogeneity in Human Follicular Lymphoma,"LEVY, RONALD",STANFORD UNIVERSITY,CA,"$473,177"
Lymphoma,2014,NCI,5R01CA160256-03,,Temporal and Spatial Control of V(D)J Recombination,"DESIDERIO, STEPHEN",JOHNS HOPKINS UNIVERSITY,MD,"$326,066"
Lymphoma,2014,NCI,5R01CA167093-03,,Myc-directed control of mRNA turnover in lymphopoiesis and lymphomagenesis,"CLEVELAND, JOHN",SCRIPPS FLORIDA,FL,"$383,525"
Lymphoma,2014,NCI,5R01CA113969-10,,RhoH GTPase in Hematopoiesis and Cancer,"WILLIAMS, DAVID",CHILDREN'S HOSPITAL CORPORATION,MA,"$315,782"
Lymphoma,2014,NCI,1R01CA182905-01,,Protein-coding and non-coding RNA biomarkers for early detection of CLL,"CALIN, GEORGE",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$573,195"
Lymphoma,2014,NCI,5R01CA166219-03,,Molecular epidemiology of non-Hodgkin lymphoma prognosis and prevention,"WANG, SOPHIA",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$620,882"
Lymphoma,2014,NIAID,1R01AI105114-01A1,,Viral Interface with an Interferon-Induced Gene,"REICH, NANCY",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$462,573"
Lymphoma,2014,NCI,5R01CA156674-04,,A Fourth Outcome: DNA Damage and the Differentiation of B Cells,"TEITELL, MICHAEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$305,437"
Lymphoma,2014,NCI,1R01CA182947-01,,Inhibition of PGE2 for mobilization of autologous peripheral blood stem cells,"FARAG, SHERIF",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$349,482"
Lymphoma,2014,NCI,1K99CA175179-01A1,,Dissecting the Genetics Of Follicular Lymphoma To Find New Therapies,"ORICCCHIO, ELISA",SLOAN-KETTERING INST CAN RESEARCH,NY,"$147,658"
Lymphoma,2014,NCI,5P01CA109901-10,7134,Mechanisms of Transformation by TAL1/SCL in Thymic Malignancy,"LOOK, A",DANA-FARBER CANCER INST,MA,"$682,792"
Lymphoma,2014,NCI,5P01CA109901-10,7135,Molecular Pathways in T Cell Development and T-ALL,"VON BOEHMER, HARALD",DANA-FARBER CANCER INST,MA,"$154,389"
Lymphoma,2014,NCI,5R01CA113809-08,,Role of Missing Metastasis Gene in tumor progression,"ZHAN, STEVEN",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$256,625"
Lymphoma,2014,NCI,5P01CA109901-10,7136,The Molecular Function of D-cyclins in T-ALL,"SICINSKI, PETER",DANA-FARBER CANCER INST,MA,"$224,001"
Lymphoma,2014,NCI,5P01CA109901-10,7137,Role of DNA Double Strand Break Response in Suppression of Thymic Lymphoma,"ALT, FREDERICK","IMMUNE DISEASE INSTITUTE, INC.",MA,"$476,740"
Lymphoma,2014,NCI,5P01CA109901-10,7138,Epigenomic Changes in Normal T-cell Development and Leukemogenesis,"YOUNG, RICHARD",WHITEHEAD INSTITUTE FOR BIOMEDICAL RES,MA,"$309,276"
Lymphoma,2014,NCI,5P01CA109901-10,7139,Administrative Core,"LOOK, A",DANA-FARBER CANCER INST,MA,"$54,673"
Lymphoma,2014,NCI,5P01CA109901-10,7140,Biostatistics and Bioinformatics Core,"NEUBERG, DONNA",DANA-FARBER CANCER INST,MA,"$48,385"
Lymphoma,2014,NCI,5R01CA170023-02,,Roles of Epstein-Barr virus nuclear antigens 2 and LP in B cell proliferation,"KIEFF, ELLIOTT",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$355,670"
Lymphoma,2014,NCI,5R03CA171052-02,,Identification of Novel Viruses Associated with Malignant Diseases,"SALYAKINA, DARIA",UNIVERSITY OF MIAMI CORAL GABLES,FL,"$69,515"
Lymphoma,2014,NCI,1K99CA175181-01A1,,The role of viral and cellular miRNAs in B-cell lymphomagenesis,"SKALSKY, REBECCA",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$99,956"
Lymphoma,2014,NIAID,1R01AI109644-01,,Differential mechanisms for RORgammat-regulated thymocyte development and Th17 di,"SUN, ZUOMING",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$420,000"
Lymphoma,2014,NIAID,5R01AI084905-06,,Regulation of B cell development by the proto-oncogene LRF/Pokemon,"MAEDA, TAKAHIRO",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$418,238"
Lymphoma,2014,NCI,5R01CA154674-04,,Cotranslational Functions of MTOR,"JACINTO, ESTELA",RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL,NJ,"$318,417"
Lymphoma,2014,NCI,5R01CA070723-17,,Genetic Analysis of EBV's Immortalizing Genes,"SUGDEN, WILLIAM",UNIVERSITY OF WISCONSIN-MADISON,WI,"$282,840"
Lymphoma,2014,NCI,5F31CA167999-03,,Role of HSF1 in B cell activation and lymphoma,"FERNANDO, THARU",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$42,676"
Lymphoma,2014,NCI,1R03CA182984-01,,Development of Integrated Analysis Methods and Applications to TCGA data,"MA, SHUANGGE",YALE UNIVERSITY,CT,"$83,250"
Lymphoma,2014,NIAID,5R01AI076183-12,,Structural and Functional Studies of gp42 and HLA Class 2 in EBV Entry,"LONGNECKER, RICHARD",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$507,585"
Lymphoma,2014,NCI,5R03CA176768-02,,Lifestyle Factors and Lymphoma: An Asia Cohort Consortium Pooling Project,"CHIU, BRIAN",UNIVERSITY OF CHICAGO,IL,"$85,606"
Lymphoma,2014,NCI,1R21CA175912-01A1,,Cellular and Biologic Origins of CLL,"DAVIS, RANDALL",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$191,835"
Lymphoma,2014,NIAID,1R21AI105340-01A1,,A recombinant virus approach for gamma herpesvirus oncogenesis,"FENG, PINGHUI",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$246,313"
Lymphoma,2014,NCI,1R21CA175821-01A1,,The role of b-catenin/Tcf-1 signaling in T-cell leukemia/lymphoma,"GOUNARI, FOTINI",UNIVERSITY OF CHICAGO,IL,"$166,981"
Lymphoma,2014,NCI,1R03CA175426-01A1,,"Function on Non-Coding RNA, MALAT1, in B-cell development and Lymphoma","RAO, DINESH",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$77,000"
Lymphoma,2014,NCI,5K23CA154874-02,,Optimization of adoptive immunotherapy with autologous CD20-specific T cells,"TILL, BRIAN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$171,720"
Lymphoma,2014,NCI,1U01CA183012-01,,Stem Cell Gene Therapy Following R-EPOCH for Non-Hodgkin Lymphoma in AIDS Patient,"ZAIA, JOHN",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$465,641"
Lymphoma,2014,NIAID,5R01AI023283-29,,Molecular Basis of Immunoglobulin Heavy Chain Switch,"SCHRADER, CAROL",UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,"$454,278"
Lymphoma,2014,NIAID,5R01AI101046-03,,Intercellular communication in Epstein Barr virus reactivation,"FLEMINGTON, ERIK",TULANE UNIVERSITY OF LOUISIANA,LA,"$376,250"
Lymphoma,2014,NCI,5R01CA174794-02,,Brain Integrity in Survivors of Childhood Cancer Treated with Thoracic Radiation,"KRULL, KEVIN",ST. JUDE CHILDREN'S RESEARCH HOSPITAL,TN,"$688,198"
Lymphoma,2014,NCI,5P30CA086862-14,8601,Cancer Immunology and Immunotherapy,"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$41,754"
Lymphoma,2014,NCI,5R01CA124332-08,,Regulation of KSHV infection and replication by MAPK pathways,"GAO, SHOU-JIANG",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$293,855"
Lymphoma,2014,NCI,5P30CA086862-14,8684,Protocol Specific Research Support,"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$44,559"
Lymphoma,2014,NCI,5R01CA152923-04,,FLT-PET/CT for Therapy Monitoring of DLBCL,"QUON, ANDREW",STANFORD UNIVERSITY,CA,"$344,120"
Lymphoma,2014,NCI,5R01CA166741-03,,Anticancer drug-induced BH3-only protein.Bak interactions,"KAUFMANN, SCOTT",MAYO CLINIC ROCHESTER,MN,"$311,815"
Lymphoma,2014,NIAID,5R01AI087634-05,,The Role of miR-17~92 in Autoimmune Diseases,"XIAO, CHANGCHUN",SCRIPPS RESEARCH INSTITUTE,CA,"$423,002"
Lymphoma,2014,NCI,5F31CA171532-02,,Identifying Regulators of Oncogenic CARD11 in Diffuse Large B Cell Lymphoma,"MACKIE, DEMAURI",JOHNS HOPKINS UNIVERSITY,MD,"$42,676"
Lymphoma,2014,NCI,5F30CA174232-02,,Combination therapies with interleukin-21 in chronic lymphocytic leukemia,"BROWNING, REBEKAH",OHIO STATE UNIVERSITY,OH,"$36,708"
Lymphoma,2014,NCI,5R01CA063417-14,,PROLIFERATIVE EFFECTS OF HTLV-1,"RATNER, LEE",WASHINGTON UNIVERSITY,MO,"$153,882"
Lymphoma,2014,NCI,5R21CA175560-02,,A new technology to isolate RNP complexes of a polycistronic miRNA oncogene,"HE, LIN",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$194,176"
Lymphoma,2014,NCI,5R01CA129037-07,,Replicative Senescence as a Tumor Suppressive Mechanism,"CHANG, SANDY",YALE UNIVERSITY,CT,"$284,560"
Lymphoma,2014,NCI,5R01CA177292-02,,Targeted Therapy for Lymphoid Malignancies,"BYRD, JOHN",OHIO STATE UNIVERSITY,OH,"$520,184"
Lymphoma,2014,NCI,1R43CA183107-01,,The Development of Novel Inhibitors of BCL2 Gene Expression as Anticancer Therape,"SIDDIQUI-JAIN, ADAM","TETRAGENE, LLC",UT,"$224,998"
Lymphoma,2014,NCI,1R41CA186101-01,,Novel scFv-Antibody Fusion siRNA Carrier Protein for Macroglobulinemia Treatment,"GARAVITO, R","SIRNAX, INC.",MI,"$224,921"
Lymphoma,2014,NCI,5R01CA177319-02,,The Role of NOTCH1 in the Pathogenesis of CLL.,"DALLA-FAVERA, RICCARDO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$347,566"
Lymphoma,2014,NHLBI,5R01HL084353-09,,"Zfx, a novel transcriptional regulator of hematopoiesis","REIZIS, BORIS",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$391,102"
Lymphoma,2014,NCI,5R01CA138636-05,,BETR Therapy for Herpesvirus-Associated Tumors,"POMPER, MARTIN",JOHNS HOPKINS UNIVERSITY,MD,"$520,698"
Lymphoma,2014,NCI,1R41CA183197-01,,Developing Therapeutics That Target RAD51 to Treat Leukemia and Lymphoma,"MILLS, KEVIN","CYTEIR THERAPEUTICS, INC.",IL,"$213,466"
Lymphoma,2014,NIDCR,5R01DE019811-05,,Cell Penetrating Helical Peptide Inhibitors of vFLIP K13,"CHAUDHARY, PREET",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$388,922"
Lymphoma,2014,NIAID,5R01AI089882-06,,Molecular elucidation of the CBM complex in NF-kappaB activation by antigen recep,"WU, HAO",CHILDREN'S HOSPITAL CORPORATION,MA,"$387,585"
Lymphoma,2014,NIGMS,5R01GM095606-04,,Coiled-coil Based Drug-Free Macromolecular Therapeutics,"KOPECEK, JINDRICH",UNIVERSITY OF UTAH,UT,"$283,100"
Lymphoma,2014,NCI,1R44CA183316-01,,A Phase I trial combining IV fenretinide and IV safingol to target overproduction,"SIMPSON, WILLIAM","CERRX, INC.",TX,"$190,601"
Lymphoma,2014,NCI,2R44CA171469-02,,Molecular Kits and Software for Lymphoid Malignancy Work-ups,"JOHNSON, DAVID","GIGAGEN, INC.",CA,"$656,240"
Lymphoma,2014,NIDDK,1F32DK101163-01,,Role of Inflammatory B cells in Liver Fibrosis and Chronic HCV Infection,"THAPA, MANOJ",EMORY UNIVERSITY,GA,"$55,094"
Lymphoma,2014,NCI,1R43CA183414-01,,CLL Mutation Detection and Monitoring from Blood using AC Electrokinetics,"KRISHNAN, RAJARAM","BIOLOGICAL DYNAMICS, INC.",CA,"$224,603"
Lymphoma,2014,NCI,1R13CA183132-01,,Bridging the gap from discovery to survival in the InterLymph Consortium,"WANG, SOPHIA",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$10,000"
Lymphoma,2014,NIGMS,5SC3GM103713-02,,Characterization of novel compounds with anti-lymphoma activity,"AGUILERA, RENATO",UNIVERSITY OF TEXAS EL PASO,TX,"$113,250"
Lymphoma,2014,NCI,1R21CA183445-01,,GSK3 inhibition as an adjuvant therapy for Burkitt's lymphoma,"THOMAS-TIKHONENKO, ANDREI",CHILDREN'S HOSP OF PHILADELPHIA,PA,"$146,160"
Lymphoma,2014,NCI,1R01CA183444-01,,Molecular Evaluation of Targeted Therapies in Lymphoid Malignancies,"BYRD, JOHN",OHIO STATE UNIVERSITY,OH,"$500,541"
Lymphoma,2014,NCI,5F32CA177139-02,,The Role of CD4+ T Cells in Oncogene Addiction,"CASEY, STEPHANIE",STANFORD UNIVERSITY,CA,"$53,282"
Lymphoma,2014,NCI,5R01CA162411-02,,Novel monocyte effector function in CLL immune therapy,"TRIDANDAPANI, SUSHEELA",OHIO STATE UNIVERSITY,OH,"$309,712"
Lymphoma,2014,NIGMS,5R44GM096494-03,,Using Aldehyde Tags to Generate Site-Specifically Modified Antibody Drug Conjugat,"RABUKA, DAVID","REDWOOD BIOSCIENCE, INC.",CA,"$669,945"
Lymphoma,2014,NCI,5F31CA177092-02,,Cyclin D3 and DNA double strand breaks: genome stability and lymphomagenesis,"DEMICCO, AMY",UNIVERSITY OF PENNSYLVANIA,PA,"$42,676"
Lymphoma,2014,NINDS,5R21NS081447-02,,Identification of Immune modulators associated with JC virus replication,"GORDON, JENNIFER",TEMPLE UNIV OF THE COMMONWEALTH,PA,"$231,660"
Lymphoma,2014,NCI,5R01CA072649-16,,Somatic Mutation of IG Variable Regions,"SCHARFF, MATTHEW",ALBERT EINSTEIN COLLEGE OF MEDICINE,NY,"$382,965"
Lymphoma,2014,NCI,5R01CA109232-10,,Regulation of the KSHV Latent Promoter,"DITTMER, DIRK",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$227,369"
Lymphoma,2014,NCI,5R01CA147791-05,,K-Rta as a Novel SUMO and Epigenetic Regulator,"IZUMIYA, YOSHIHIRO",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$300,665"
Lymphoma,2014,NCI,5R01CA162964-04,,Antibody-interferon fusion proteins for treatment of B-cell malignancies,"MORRISON, SHERIE",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$309,964"
Lymphoma,2014,NCI,5R01CA155010-04,,Personal tumor neoantigens for immunity against chronic lymphocytic leukemia,"WU, CATHERINE",DANA-FARBER CANCER INST,MA,"$352,231"
Lymphoma,2014,NCI,5R01CA159296-03,,Novel Immunotherapies for Lymphoid Malignancies,"BYRD, JOHN",OHIO STATE UNIVERSITY,OH,"$306,945"
Lymphoma,2014,NCI,5R01CA166325-03,,Mechanisms promoting translocations and mature B cell lymphomas,"WANG, JING",UNIVERSITY OF COLORADO DENVER,CO,"$312,164"
Lymphoma,2014,NCI,5R01CA151955-05,,A bifunctional nanomedicine for both specific imaging and targeting therapy of an,"ZU, YOULI",METHODIST HOSPITAL RESEARCH INSTITUTE,TX,"$300,665"
Lymphoma,2014,NCI,5P50CA094056-14,7927,Imaging NFkB Activation in HTLV Lymphoma,"RATNER, LEE",WASHINGTON UNIVERSITY,MO,"$156,626"
Lymphoma,2014,NCI,5R01CA151351-04,,Exploring the role of the de-ubiquitinase UCH-L1 in B-cell malignancy,"GALARDY, PAUL",MAYO CLINIC ROCHESTER,MN,"$317,411"
Lymphoma,2014,NCI,5F30CA168358-03,,The interaction of Burkitt???s lymphoma cofactors EBV and Plasmodium,"WOHLFORD, ERIC",UPSTATE MEDICAL UNIVERSITY,NY,"$47,147"
Lymphoma,2014,NIBIB,5R01EB001994-15,,Imaging Based Dosimetry for Individualized Internal Emitter Therapy,"DEWARAJA, YUNI",UNIVERSITY OF MICHIGAN,MI,"$442,741"
Lymphoma,2014,NCI,5R01CA154643-05,,Resequencing and Functional Studies to Identify Causal Gene Variants of Lymphoma,"SKIBOLA, CHRISTINE",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$532,823"
Lymphoma,2014,NIAID,1R01AI110328-01,,Viral Long Noncoding RNA Functions in Epstein-Barr Virus Infection,"SAMPLE, JEFFERY",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$367,540"
Lymphoma,2014,NIAID,1R21AI108597-01A1,,Topology of the Hosthogen Genome,"MIRANDA, JJ",J. DAVID GLADSTONE INSTITUTES,CA,"$286,500"
Lymphoma,2014,NCI,5U01CA168426-03,,Systems Biology of Tumor Progression and Drug Resistance,"CALIFANO, ANDREA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$1,165,605"
Lymphoma,2014,NCI,5R01CA160300-04,,Cellular Response to Short Telomeres in B-Cell Lymphoma,"GREIDER, CAROL",JOHNS HOPKINS UNIVERSITY,MD,"$505,504"
Lymphoma,2014,NIAID,5R01AI067968-08,,Role and mechanism of action of gamma herpesvirus microRNAs,"CULLEN, BRYAN",DUKE UNIVERSITY,NC,"$392,500"
Lymphoma,2014,NCI,5R03CA156561-02,,Clinical characteristics and patterns of care for rare brain tumor sub-types,"VILLANO, JOHN",UNIVERSITY OF KENTUCKY,KY,"$74,116"
Lymphoma,2014,NIEHS,5R01ES021832-02,,Endocrine disrupter modulation of SXR in development and lymphomagenesis,"BLUMBERG, BRUCE",UNIVERSITY OF CALIFORNIA-IRVINE,CA,"$343,685"
Lymphoma,2014,NIAID,5R01AI081710-05,,Mechanisms of KSHV post-transcriptional gene regulation,"CONRAD, NICHOLAS",UT SOUTHWESTERN MEDICAL CENTER,TX,"$330,244"
Lymphoma,2014,NIEHS,5R01ES020116-05,,Epigenomic profiling of histone turnover kinetics in mammalian cells,"HENIKOFF, STEVEN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$476,486"
Lymphoma,2014,NIGMS,1R01GM110052-01,,Functional roles of lipids in early B cell receptor signaling.,"VEATCH, SARAH",UNIVERSITY OF MICHIGAN,MI,"$289,541"
Lymphoma,2014,NCI,1R01CA183876-01,,Towards The Chemotherapy-Free Treatment of Follicular Lymphoma,"WENDEL, HANS-GUIDO",SLOAN-KETTERING INST CAN RESEARCH,NY,"$567,773"
Lymphoma,2014,NCI,1R01CA184384-01,,Prognostic Metabolic Signatures of Cancers Through Mass Spectrometry Imaging,"FELSHER, DEAN",STANFORD UNIVERSITY,CA,"$569,601"
Lymphoma,2014,NCI,5P01CA022443-37,6859,Controlling the Latent-to-Lytic Switch in Epstein-Barr Virus,"MERTZ, JANET",UNIVERSITY OF WISCONSIN-MADISON,WI,"$337,329"
Lymphoma,2014,NCI,5P01CA022443-37,6863,miRNA and v-Cdks: Independent Drivers OF EBV and HCMV Replication and Oncogenesi,"KENNEY, SHANNON",UNIVERSITY OF WISCONSIN-MADISON,WI,"$383,420"
Lymphoma,2014,NCI,1K24CA184039-01,,Molecularly Targeted Therapy for Lymphoma,"GOPAL, AJAY",UNIVERSITY OF WASHINGTON,WA,"$186,231"
Lymphoma,2014,NCI,5R01CA076445-14,,Studies of HHV-8 vIL-6 Function,"NICHOLAS, JOHN",JOHNS HOPKINS UNIVERSITY,MD,"$339,078"
Lymphoma,2014,NCI,5R01CA085563-12,,"ROS, Redox Regulation and Novel Targets for Cancer Therapy","HUANG, PENG",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$226,572"
Lymphoma,2014,NCI,5R01CA104348-10,,Transcriptional silencing by the BCL6 oncoprotein,"MELNICK, ARI",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$241,708"
Lymphoma,2014,NCI,5R01CA106258-10,,HTLV-I Tax induces DNA breaks and inhibits HR repair through activation of NF-kB,"NICOT, CHRISTOPHE",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$217,289"
Lymphoma,2014,NCI,5R01CA117794-09,,Inhibitors of the Epstein-Barr Virus Entry Machinery,"JARDETZKY, THEODORE",STANFORD UNIVERSITY,CA,"$321,272"
Lymphoma,2014,NCI,5R01CA160556-04,,Escape from gammaherpesvirus-induced mRNA destruction,"GLAUNSINGER, BRITT",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$300,791"
Lymphoma,2014,NCI,5R37CA031845-34,,Synthetic Studies Related to Cancer Research/Treatment,"WENDER, PAUL",STANFORD UNIVERSITY,CA,"$430,552"
Lymphoma,2014,NCI,5K23CA160345-04,,Targeting Akt Activation in CLL,"DING, WEI",MAYO CLINIC ROCHESTER,MN,"$167,400"
Lymphoma,2014,NCI,5R01CA047006-27,,Epstein-Barr Virus Nuclear Protein in B Cell Growth Transformation,"KIEFF, ELLIOTT",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$548,274"
Lymphoma,2014,NCI,5R01CA090571-13,,"CRTC2 in Cellular Development, Function, and Neoplasia","TEITELL, MICHAEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$264,840"
Lymphoma,2014,NCI,5R01CA129974-08,,Probing mitochondria and personalizing leukemia therapy with BH3 profiling,"LETAI, ANTHONY",DANA-FARBER CANCER INST,MA,"$305,698"
Lymphoma,2014,NCI,5K08CA158069-04,,The Role of Heme Metabolic Pathways in T Cell Development and T Cell Lymphomagene,"PHILIP, MARY",UNIVERSITY OF WASHINGTON,WA,"$167,400"
Lymphoma,2014,NCI,1R03CA184127-01,,A Novel Multimodality Immune Based Platform in Advanced Mycosis Fungoides,"DIEFENBACH, CATHERINE",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$84,750"
Lymphoma,2014,NCI,5U01CA174844-02,,A Drug Delivery Strategy for Targeted Therapy of Chronic Lymphocytic Leukemia,"RADER, CHRISTOPH",SCRIPPS FLORIDA,FL,"$465,155"
Lymphoma,2014,NHLBI,5U10HL069233-14,,Nebraska/Kansas Blood and Marrow Transplant Research Network,"VOSE, JULIE",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$154,372"
Lymphoma,2014,NHLBI,5U10HL108945-04,,Anti-viral and antileukemic T-cell therapy as prophylaxis after HSCT,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$160,218"
Lymphoma,2014,NHLBI,5U10HL109322-04,,The Ohio State Blood and Marrow Transplant Reseach Consortium,"DEVINE, STEVEN",OHIO STATE UNIVERSITY,OH,"$151,219"
Lymphoma,2014,NCI,1K23CA184279-01,,Molecular determinants of prognosis in limited-stage follicular lymphoma,"LOUISSAINT, ABNER",MASSACHUSETTS GENERAL HOSPITAL,MA,"$140,263"
Lymphoma,2014,NCI,5R01CA151533-04,,Role of IGF-IR tyrosine kinase in NPM-ALK-expressing T-cell lymphoma,"AMIN, HESHAM",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$318,015"
Lymphoma,2014,NCI,5R01CA164311-04,,MAP Kinase Signaling in Lymphoma: A Novel Therapeutic Paradigm,"EVENS, ANDREW",TUFTS MEDICAL CENTER,MA,"$335,991"
Lymphoma,2014,NCI,5R01CA141070-04,,Role of the mitochondrial RNA polymerase POLRMT in MYC function,"MCMAHON, STEVEN",THOMAS JEFFERSON UNIVERSITY,PA,"$280,780"
Lymphoma,2014,NCI,5K05CA160724-04,,Survivorship: Mentoring and Bridging Primary Care and Oncology,"OEFFINGER, KEVIN",SLOAN-KETTERING INST CAN RESEARCH,NY,"$164,278"
Lymphoma,2014,NCI,5P30AI027757-27,7315,HIV-Associated Malignancies (HIVAM),"HOLMES, KING",UNIVERSITY OF WASHINGTON,WA,"$30,150"
Lymphoma,2014,NHLBI,5P30AI027757-27,7315,HIV-Associated Malignancies (HIVAM),"HOLMES, KING",UNIVERSITY OF WASHINGTON,WA,"$21,585"
Lymphoma,2014,NIA,5P30AI027757-27,7315,HIV-Associated Malignancies (HIVAM),"HOLMES, KING",UNIVERSITY OF WASHINGTON,WA,"$1,553"
Lymphoma,2014,NIAID,5P30AI027757-27,7315,HIV-Associated Malignancies (HIVAM),"HOLMES, KING",UNIVERSITY OF WASHINGTON,WA,"$158,031"
Lymphoma,2014,NICHD,5P30AI027757-27,7315,HIV-Associated Malignancies (HIVAM),"HOLMES, KING",UNIVERSITY OF WASHINGTON,WA,"$6,373"
Lymphoma,2014,NIDA,5P30AI027757-27,7315,HIV-Associated Malignancies (HIVAM),"HOLMES, KING",UNIVERSITY OF WASHINGTON,WA,"$15,303"
Lymphoma,2014,NIDDK,5P30AI027757-27,7315,HIV-Associated Malignancies (HIVAM),"HOLMES, KING",UNIVERSITY OF WASHINGTON,WA,"$9,462"
Lymphoma,2014,NIGMS,5P30AI027757-27,7315,HIV-Associated Malignancies (HIVAM),"HOLMES, KING",UNIVERSITY OF WASHINGTON,WA,"$9,462"
Lymphoma,2014,OD,5P30AI027757-27,7315,HIV-Associated Malignancies (HIVAM),"HOLMES, KING",UNIVERSITY OF WASHINGTON,WA,"$85,880"
Lymphoma,2014,NIAID,1R21AI111129-01,,Uracil DNA glycosylases in herpesvirus pathogenesis and DNA mutation,"KRUG, LAURIE",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$210,717"
Lymphoma,2014,NCI,1R21CA184694-01,,Targeted Therapies in CNS Lymphomas,"RUBENSTEIN, JAMES","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$171,553"
Lymphoma,2014,NCI,5R01CA164346-03,,CHARACTERIZATION AND TARGETED THERAPY OF T-ALL DEFICIENT FOR PTEN AND INK4A/ARF,"YOU, M. JAMES",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$291,001"
Lymphoma,2014,NCI,5P30CA124435-08,6484,Lymphoma,"LEVY, RONALD",STANFORD UNIVERSITY,CA,"$52,923"
Lymphoma,2014,NCI,5P30CA124435-08,6543,Hematopoetic,"NEGRIN, ROBERT",STANFORD UNIVERSITY,CA,"$52,923"
Lymphoma,2014,NCI,5R01CA161026-04,,Complementary Signaling Pathways In Hodgkin Lymphoma and Related Malignancies,"SHIPP, MARGARET",DANA-FARBER CANCER INST,MA,"$413,783"
Lymphoma,2014,NCI,5R01CA164641-02,,Natural Killer Cell Regulation by PRDM1 and IRF4/8,"WRIGHT, KENNETH",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$305,234"
Lymphoma,2014,NCI,5R01CA168477-03,,Immune Modulation by Gammaherpesviruses,"COSCOY, LAURENT",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$250,356"
Lymphoma,2014,NCI,5R01CA168558-03,,Cyclin requirements in gammaherpesvirus infection and disease,"VAN DYK, LINDA",UNIVERSITY OF COLORADO DENVER,CO,"$298,913"
Lymphoma,2014,NCI,1R01CA184922-01,,(PQD1) lmpact of cytotoxic and targeted therapy on clonal evolution of CLL,"WU, CATHERINE",DANA-FARBER CANCER INST,MA,"$553,684"
Lymphoma,2014,NCI,5U01CA157581-04,,Molecular Diagnosis and Prognosis in Aggressive Lymphoma,"RIMSZA, LISA",UNIVERSITY OF ARIZONA,AZ,"$565,864"
Lymphoma,2014,NCI,5P01CA019014-35,6231,DNA-Protein Interactions in Herpes Viruses,"GRIFFITH, JACK",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$262,683"
Lymphoma,2014,NCI,5P01CA019014-35,6234,Cellular Reprogramming by KSHV Latent Genes and miRNAs,"DITTMER, DIRK",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$283,421"
Lymphoma,2014,NCI,5P01CA019014-35,6235,Transformation by EBV Latent Membrane Proteins 1 and 2 (LMP1 and LMP2),"RAAB-TRAUB, NANCY",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$283,521"
Lymphoma,2014,NCI,5R01CA158402-03,,Molecular mechanisms of B cell malignant transformation,"XIE, PING","RUTGERS, THE STATE UNIV OF N.J.",NJ,"$312,783"
Lymphoma,2014,NCI,1R21CA185236-01,,(PQD5)Biomaterials-based Adaptive Tumor Microenvironments for In Vitro Drug Scree,"SINGH, ANKUR",CORNELL UNIVERSITY,NY,"$179,619"
Lymphoma,2014,NCI,1R01CA185372-01,,(PQD5) A novel genetic strategy to predict efficacy of anti-CD20 antibodies,"RICHARDS, KRISTY",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$329,519"
Lymphoma,2014,NCI,1R21CA185508-01,,(PQA2) Impact of obesity on endogenous mutational hotspots,"VASQUEZ, KAREN","UNIVERSITY OF TEXAS, AUSTIN",TX,"$201,623"
Lymphoma,2014,FIC,5K01TW009488-03,,Developing a clinical cohort of histopathologically characterized lymphoma,"GOPAL, SATISH",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$140,175"
Lymphoma,2014,NIAID,1R21AI105751-01A1,,"Chronic Fatigue Syndrome, Immune Dysregulation, and Non-Hodgkin's Lymphoma","MOSLEHI, ROXANA",STATE UNIVERSITY OF NEW YORK AT ALBANY,NY,"$273,447"
Lymphoma,2014,NCI,5U54CA155496-04,5936,Social Determinants in the Link between Obesity and Cancer,"HOVMAND, PETER",WASHINGTON UNIVERSITY IN ST LOUIS,,"$194,062"
Lymphoma,2014,NCI,5P50CA097274-13,7186,In Situ Immunization Using Nanoparticles,"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$182,443"
Lymphoma,2014,NCI,5P50CA097274-13,7184,The Role of Monocytes in non-Hodgkin Lymphoma,"ANSELL, STEPHEN",UNIVERSITY OF IOWA,IA,"$279,492"
Lymphoma,2014,NCI,5P50CA097274-13,7191,Genetic Epidemiology and Function of Germline and Somatic Variants in DLBCL,"CERHAN, JAMES",UNIVERSITY OF IOWA,IA,"$272,471"
Lymphoma,2014,NCI,5P50CA097274-13,7189,Targeting JAK2 Kinase in Lymphoma,"GUPTA, MAMTA",UNIVERSITY OF IOWA,IA,"$274,658"
Lymphoma,2014,NCI,5P50CA097274-13,7192,Administration,"WEINER, GEORGE",UNIVERSITY OF IOWA,IA,"$133,155"
Lymphoma,2014,NCI,5P50CA097274-13,7194,Biospecimens,"DOGAN, AHMET",UNIVERSITY OF IOWA,IA,"$278,790"
Lymphoma,2014,NCI,5P50CA097274-13,7195,Biostatistics and Bioinformatics,"SMITH, BRIAN",UNIVERSITY OF IOWA,IA,"$194,749"
Lymphoma,2014,NCI,5P50CA097274-13,7197,DEVELOPMENTAL RESEARCH PROGRAM,"LENTZ, STEVEN",UNIVERSITY OF IOWA,IA,"$150,818"
Lymphoma,2014,NCI,5P50CA097274-13,7196,Clinical Research,"HABERMANN, THOMAS",UNIVERSITY OF IOWA,IA,"$301,906"
Lymphoma,2014,NCI,5P50CA097274-13,7198,CAREER DEVELOPMENT PROGRAM,"HOHL, RAYMOND",UNIVERSITY OF IOWA,IA,"$93,520"
Lymphoma,2014,RMAP,5R01CA174385-03,,Quantitative single-cell biomarkers of T-cells to optimize tumor immunotherapy,"VARADARAJAN, NAVIN",UNIVERSITY OF HOUSTON,TX,"$457,521"
Lymphoma,2014,NCI,5R21CA178344-02,,Anthraycline-related cardiotoxicity in long-term survivors of lymphoma,"ARMENIAN, SARO",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$155,521"
Lymphoma,2014,NCI,5R21CA178424-02,,CD164 as a novel biomarker for malignant CD4 T cells in cutaneous T cell lymphoma,"WYSOCKA, MARIA",UNIVERSITY OF PENNSYLVANIA,PA,"$168,781"
Lymphoma,2014,NCI,5P30CA125123-08,6427,PROGRAM LEADERS,"OSBORNE, C",BAYLOR COLLEGE OF MEDICINE,TX,"$32,618"
Lymphoma,2014,NCI,5P30CA125123-08,6486,HUMAN TISSUE ACQUISITION AND PATHOLOGY,"AYALA, GUSTAVO",BAYLOR COLLEGE OF MEDICINE,TX,"$126,826"
Lymphoma,2014,NCI,5P30CA125123-08,6609,Program leaders---cell and gene therapy,"BRENNER, MALCOLM",BAYLOR COLLEGE OF MEDICINE,TX,"$13,118"
Lymphoma,2014,NCI,1R21CA185833-01,,Epigenetic regulation of T-cell dysfunction in chronic lymphocytic leukemia,"SHI, HUIDONG",GEORGIA  REGENTS UNIVERSITY,GA,"$196,947"
Lymphoma,2014,NCI,1R21CA179302-01A1,,Characterization of a non-canonical role for Foxo1 in B cell lymphoma,"RICKERT, ROBERT",SANFORD-BURNHAM MEDICAL RESEARCH INSTIT,CA,"$254,475"
Lymphoma,2014,NIAMS,5R01AR063962-02,,CTCL immunobiology: lessons from alemtuzumab,"CLARK, RACHAEL",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$361,810"
Lymphoma,2014,NCI,5P30CA082103-16,6392,Hematopoietic Malignancies,"MCCORMICK, FRANK","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,$137
Lymphoma,2014,NCI,5U01CA166905-02,,Identifying non-coding RNAs for early detection and prevention of lung cancer,"CROCE, CARLO",OHIO STATE UNIVERSITY,OH,"$851,643"
Lymphoma,2014,NCI,2R01CA137488-19A1,,Two Compartment Models to Improve Brain Tumor Therapy,"NEUWELT, EDWARD",OREGON HEALTH & SCIENCE UNIVERSITY,OR,"$485,308"
Lymphoma,2014,NIAID,2R37AI037526-20A1,,Class Switch Recombination in B Lymphocytes,"NUSSENZWEIG, MICHEL",ROCKEFELLER UNIVERSITY,NY,"$423,750"
Lymphoma,2014,NCI,2P30CA023100-28,6336,Hematologic Malignancies,"LIPPMAN, SCOTT",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$26,793"
Lymphoma,2014,NCI,5P30CA046592-26,6464,Hematologic Malignancies/BMT,"WICHA, MAX",UNIVERSITY OF MICHIGAN,MI,"$312,601"
Lymphoma,2014,NHLBI,5K01HL103182-05,,The Role of hPso4 in DNA Repair and Chemotherapy Resistance,"SHAHEEN, MONTASER",UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR,NM,"$135,657"
Lymphoma,2014,NCI,1R01CA178453-01A1,,Role of MEF2B mutations in lymphomagenesis,"DALLA-FAVERA, RICCARDO",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$443,555"
Lymphoma,2014,NCI,1F31CA186237-01,,Development of a Coiled-Coil therapeutic for Non-Hodgkin's Lymphoma,"HARTLEY, JONATHAN",UNIVERSITY OF UTAH,UT,"$31,756"
Lymphoma,2014,NCI,5R01CA103646-08,,Modeling KSHV latency in vivo,"CESARMAN, ETHEL",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$318,644"
Lymphoma,2014,NCI,5R01CA140337-04,,Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation,"LUFTIG, MICAH",DUKE UNIVERSITY,NC,"$316,002"
Lymphoma,2014,NCI,5R01CA156690-05,,TARGETING EPIGENOMIC SIGNATURES IN NON-HODGKIN LYMPHOMA FOR NOVEL THERAPEUTICS,"OLTZ, EUGENE",WASHINGTON UNIVERSITY,MO,"$289,768"
Lymphoma,2014,RMAP,5R01CA156690-05,,TARGETING EPIGENOMIC SIGNATURES IN NON-HODGKIN LYMPHOMA FOR NOVEL THERAPEUTICS,"OLTZ, EUGENE",WASHINGTON UNIVERSITY,MO,"$304,889"
Lymphoma,2014,NCI,5R01CA164679-03,,HVEM-BTLA Pathway in Lymphoma,"WARE, CARL",SANFORD-BURNHAM MEDICAL RESEARCH INSTIT,CA,"$392,486"
Lymphoma,2014,NCI,5R01CA151319-04,,TOWARD AN UNDERSTANDING OF CLL PROGRESSION,"CROCE, CARLO",OHIO STATE UNIVERSITY,OH,"$363,375"
Lymphoma,2014,NIAID,1R21AI107237-01A1,,IRF4 Functions as a Negative Regulator of Notch Signaling in the Development of M,"LU, RUNQING",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$225,750"
Lymphoma,2014,NCI,5P01CA119070-08,7558,Notch 1 Regulation of T-ALL Genomes,"ASTER, JON",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$186,050"
Lymphoma,2014,NCI,5R01CA093606-12,,Regulation of EBV Latency by EBNA1,"LIEBERMAN, PAUL",WISTAR INSTITUTE,PA,"$311,635"
Lymphoma,2014,NCI,5R01CA165937-03,,Antiretroviral Therapy Strategies to Lower Cancer Risk in HIV-Infected Persons,"SILVERBERG, MICHAEL",KAISER FOUNDATION RESEARCH INSTITUTE,CA,"$709,818"
Lymphoma,2014,NCI,1R03CA175872-01A1,,Targeting the tumor microenvironment in B-cell malignancies,"ELSAWA, SHERINE",NORTHERN ILLINOIS UNIVERSITY,IL,"$73,500"
Lymphoma,2014,NCI,5R01CA170006-02,,Microvesicle Dynamics in B-Cell Chronic Lymphocytic Leukemia Tumor Microenvironme,"GHOSH, ASISH",MAYO CLINIC ROCHESTER,MN,"$314,327"
Lymphoma,2014,NCI,5R03CA173823-02,,Models for cumulative spatial-temporal assessment of non-Hodgkin lymphoma risk,"WHEELER, DAVID",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$73,963"
Lymphoma,2014,NCI,2R01CA076167-11,,Genetic Analysis of Myeloproliferative Disease,"COWELL, JOHN",GEORGIA  REGENTS UNIVERSITY,GA,"$305,269"
Lymphoma,2014,NCI,5K08CA140780-05,,Genetic and Proteomic Analysis of Epstein-Barr Virus LMP1 Activation of NF-kB,"GEWURZ, BENJAMIN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$179,910"
Lymphoma,2014,NIDDK,5R01DK043726-23,,Biological functions and mechanisms of action of Ikaros proteins,"SMALE, STEPHEN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$334,950"
Lymphoma,2014,NCI,1R03CA179558-01A1,,"Autoimmune Conditions, Genetic Variations, and Lymphoma Etiology","WANG, SOPHIA",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$84,000"
Lymphoma,2014,NCI,5R01CA177600-02,,Regulation of CARD11 signaling in normal and dysregulated lymphocyte development,"POMERANTZ, JOEL",JOHNS HOPKINS UNIVERSITY,MD,"$326,066"
Lymphoma,2014,NCI,5F32CA165705-03,,Effects of short-chain fatty acids on Epstein-Barr virus in B cell lymphoma,"GORRES, KELLY",YALE UNIVERSITY,CT,"$56,978"
Lymphoma,2014,NCI,5P30CA091842-13,6584,Hematopoietic Developmental Malignancy,"LINK, DANIEL",WASHINGTON UNIVERSITY,MO,"$61,006"
Lymphoma,2014,NCI,5P01CA087497-14,5109,p53 and Chemosensitivity in a Mouse Lymphoma Model,"LOWE, SCOTT",COLD SPRING HARBOR LABORATORY,NY,"$402,181"
Lymphoma,2014,NCI,5K23CA140722-05,,Nanoscale analysis of proteomic response to novel targeted therapies for lymphoma,"FAN, ALICE",STANFORD UNIVERSITY,CA,"$173,448"
Lymphoma,2014,NCI,5R00CA143231-04,,Targeting the B Cell Receptor Signaling Network in Lymphoma,"IRISH, JONATHAN",VANDERBILT UNIVERSITY,TN,"$235,049"
Lymphoma,2014,NCI,5R01CA170386-03,,Novel Pathogen Associated Cancers (PQ12),"GALLOWAY, DENISE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$722,856"
Lymphoma,2014,NCI,5R01CA140245-05,,Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk Reduction,"BHATIA, SMITA",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$519,121"
Lymphoma,2014,NCI,5R01CA163217-04,,Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma,"DITTMER, DIRK",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$296,581"
Lymphoma,2014,NCI,5K08CA172215-02,,The role of GATA-3 in T-cell lymphomas,"WILCOX, RYAN",UNIVERSITY OF MICHIGAN,MI,"$178,618"
Lymphoma,2014,NCI,5R01CA096500-12,,Role of KSHV viral proteins in signaling and pathogenesis,"DAMANIA, BLOSSOM",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$272,674"
Lymphoma,2014,NCI,5R21CA169487-02,,Epigenomic determinants of clinical outcomes in MCL patients treated on E1405,"PAREKH, SAMIR",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$178,802"
Lymphoma,2014,NCI,5F31CA171933-03,,Characterization of ER-localized Activity of HHV-8 Interleukin-6,"COUSINS, EMILY",JOHNS HOPKINS UNIVERSITY,MD,"$42,676"
Lymphoma,2014,NCI,5R01CA102667-10,,Effects of Malaria on EBV Persistence in Children,"ROCHFORD, ROSEMARY",UPSTATE MEDICAL UNIVERSITY,NY,"$306,448"
Lymphoma,2014,NCI,5R21CA178860-02,,Development of deep proteomic sequencing platforms for molecular markers in DLBCL,"DANIAL, NIKA",DANA-FARBER CANCER INST,MA,"$221,524"
Lymphoma,2014,NCI,5R01CA177734-02,,Genetic Biomarkers for Risk Assessment of Peripheral T-Cell Lymphomas,"FELDMAN, ANDREW",MAYO CLINIC ROCHESTER,MN,"$320,027"
Lymphoma,2014,NCI,5R01CA120185-08,,c-Myc-regulated microRNAs in normal and pathologic cellular physiology,"MENDELL, JOSHUA",UT SOUTHWESTERN MEDICAL CENTER,TX,"$284,246"
Lymphoma,2014,NCI,5U01CA118444-09,,Genetic Epidemiology of Chronic Lymphocytic Leukemia,"SLAGER, SUSAN",MAYO CLINIC ROCHESTER,MN,"$569,494"
Lymphoma,2014,NCI,5R44CA153676-03,,Drug candidates that disrupt the NEMO/IKK signaling complex for the treatment of,"HANSEN, STIG","CARMOT THERAPEUTICS, INC.",CA,"$924,148"
Lymphoma,2014,OD,5R21CA177315-02,,Pathobiology and Clinical Profile of HIV-Associated Cancers in India and the West,"DITTMER, DIRK",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$204,706"
Lymphoma,2014,NCI,1F32CA180499-01A1,,Targeting Chronic Lymphocytic Leukemia with DNA Nanoparticles,"RUFF, LAURA",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$53,282"
Lymphoma,2014,NIAID,1R43AI112125-01,,Non-invasive Diagnostic Platform Development for Celiac Disease Remission Status,"RIEDER, MARK",ADAPTIVE BIOTECHNOLOGIES CORPORATION,WA,"$244,699"
Lymphoma,2014,NCI,5K08CA151450-05,,Pathologic BIM Suppression & Pharmacologic BH3 Replacement in B-Cell Lymphoma,"LABELLE, JAMES",UNIVERSITY OF CHICAGO,IL,"$168,048"
Lymphoma,2014,NCI,1F30CA186456-01,,Targeting lymphoma with modular anti-idiotype peptibodies,"TORCHIA, JAMES",STANFORD UNIVERSITY,CA,"$32,875"
Lymphoma,2014,NCI,1F30CA186458-01,,High-resolution analysis of chromatin regulation by the Max network,"KASINATHAN, SIVAKANTHAN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$36,338"
Lymphoma,2014,NCI,5K24CA125440-08,,Clinical and Molecular Studies of Malignant Brain Tumors,"BATCHELOR, TRACY",MASSACHUSETTS GENERAL HOSPITAL,MA,"$185,972"
Lymphoma,2014,NCI,5F31CA165728-03,,Novel Mechanism for Myc-Induced Apoptosis,"ADAMS, CLARE",VANDERBILT UNIVERSITY,TN,"$27,036"
Lymphoma,2014,NIGMS,1F32GM110998-01,,TISSUE-SPECIFIC MECHANISMS OF EOMESODERMIN-MEDIATED TRANSCRIPTIONAL REGULATION,"SLAGLE, CHRISTOPHER",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$53,282"
Lymphoma,2014,NCI,1F31CA186532-01,,The Tumor Suppressive Role of the mir-200 family of microRNAs,"CISSON, JENNIFER",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$36,056"
Lymphoma,2014,NCI,5F31CA171400-03,,Mitochondrial Homeostasis in Metabolically Distinct Subsets of B-Cell Lymphoma,"STANLEY, ILLANA",HARVARD MEDICAL SCHOOL,MA,"$30,034"
Lymphoma,2014,NCI,5P01CA044991-26,8453,Radioimmunotherapy for Lymphoma,"GOPAL, AJAY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$258,380"
Lymphoma,2014,NCI,5P01CA044991-26,8454,Pretargeted Radioimmunotherapy for Hematologic Malignancies,"PRESS, OLIVER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$304,825"
Lymphoma,2014,NCI,5P01CA044991-26,8455,Administrative and Statistical Core,"PRESS, OLIVER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$460,927"
Lymphoma,2014,NCI,5P01CA044991-26,8456,Nuclear Medicine Core,"RAJENDRAN, JOSEPH",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$601,896"
Lymphoma,2014,NCI,5P01CA044991-26,8457,Biologics Production Core,"BALDWIN, JANELL",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$254,768"
Lymphoma,2014,NIAID,5P01AI061093-11,7981,Investigating Blocks to B Cell Memory in CVID,"CUNNINGHAM-RUNDLES, CHARLOTTE",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$319,242"
Lymphoma,2014,NCI,5R44CA162582-03,,Reducing Complement Inhibition to Treat Leukemia and Lymphoma,"CARTER, DARRICK","PAI LIFE SCIENCES, INC.",WA,"$812,715"
Lymphoma,2014,NCI,5F31CA165782-03,,"Functional analysis of cIAP2-MATL1, MALT1 and proteolytic targets in B cells","LEE, PEISHAN",SANFORD-BURNHAM MEDICAL RESEARCH INSTIT,CA,"$37,270"
Lymphoma,2014,NCI,5R01CA180150-02,,(PQD1) Treatment-emergent resistance to NEDD8-activating enzyme inhibition,"PETROSKI, MATTHEW",SANFORD-BURNHAM MEDICAL RESEARCH INSTIT,CA,"$541,578"
Lymphoma,2014,NCI,5R21CA180097-02,,(PQD2) Why is Endemic Burkitt Lymphoma Curable with Single Agent Chemotherapy?,"DITTMER, DIRK",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$192,409"
Lymphoma,2014,NCI,5K07CA140360-06,,"Molecular Epidemiology of B cell Activation, DNA Repair & HIV-Associated Lymphoma","HUSSAIN, SHEHNAZ",CEDARS-SINAI MEDICAL CENTER,CA,"$125,207"
Lymphoma,2014,NIGMS,5R01GM103843-02,,Dissecting Cell Signaling Mediated by Protein-Protein Interactions in Membranes,"YIN, HANG",UNIVERSITY OF COLORADO,CO,"$289,750"
Lymphoma,2014,NHLBI,5R01HL114564-02,,Enhancement of stem cell transplants using CAR.CD30-redirected T lymphocytes,"SAVOLDO, BARBARA",BAYLOR COLLEGE OF MEDICINE,TX,"$452,675"
Lymphoma,2014,NCI,5R21CA180815-02,,Molecular profiling of HIV-associated lymphoma in the US and Malawi,"GOPAL, SATISH",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$183,563"
Lymphoma,2014,NCI,5F31CA174239-02,,Synergy between BCR signaling and stress response,"GOLDSTEIN, REBECCA",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$42,676"
Lymphoma,2014,NCI,5P50CA126752-08,0001,T CELL THERAPY TARGETING MULTIPLE TUMOR ANTIGENS IN HODGKIN LYMPHOMA,"LEEN, ANN",BAYLOR COLLEGE OF MEDICINE,TX,"$233,476"
Lymphoma,2014,NCI,5P50CA126752-08,0002,CHIMERIC T CELL ANTIGENS TARGETING IG KAPPA LIGHT CHAIN IN B CELL LYMPHOMA,"DOTTI, GIANPIETRO",BAYLOR COLLEGE OF MEDICINE,TX,"$220,318"
Lymphoma,2014,NCI,5P50CA126752-08,0003,BUILDING ON SUCCESSFUL T CELL THERAPY FOR EBV LYMPHOMA,"ROONEY, CLIONA",BAYLOR COLLEGE OF MEDICINE,TX,"$214,762"
Lymphoma,2014,NCI,5P50CA126752-08,0004,TARGETING CHEMORESISTANT TUMOR-INITIATING CELLS IN CLL,"FOSTER, AARON",BAYLOR COLLEGE OF MEDICINE,TX,"$218,566"
Lymphoma,2014,NCI,5P50CA126752-08,0006,ADMINISTRATIVE CORE,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$140,646"
Lymphoma,2014,NCI,5P50CA126752-08,9001,Clinical Research Core,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$143,969"
Lymphoma,2014,NCI,5P50CA126752-08,9002,Biostatistics,"LIU, HAO",BAYLOR COLLEGE OF MEDICINE,TX,"$135,981"
Lymphoma,2014,NCI,5P50CA126752-08,9003,Cell and Vector Production,"GEE, ADRIAN",BAYLOR COLLEGE OF MEDICINE,TX,"$262,250"
Lymphoma,2014,NCI,5P50CA126752-08,9004,BIOSPECIMEN AND PATHOLOGY CORE,"SHEEHAN, ANDREA",BAYLOR COLLEGE OF MEDICINE,TX,"$280,412"
Lymphoma,2014,NCI,5P50CA126752-08,7045,DEVELOPMENTAL RESEARCH PROGRAM,"BRENNER, MALCOLM",BAYLOR COLLEGE OF MEDICINE,TX,"$155,811"
Lymphoma,2014,NCI,5P50CA126752-08,7046,CAREER DEVELOPMENT PROGRAM,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$155,809"
Lymphoma,2014,NCI,5R21CA173330-02,,Nanoparticle Enabled L-asparaginase Therapy for CLL,"ESENER, SADIK",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$196,207"
Lymphoma,2014,NIGMS,5R01GM107058-02,,Role of constitutive androstane receptor in cyclophosphamide-based chemotherapy,"WANG, HONGBING",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$291,650"
Lymphoma,2014,NCI,5R01CA149445-04,,A prospective analysis of peripheral blood cytokines and non-Hodgkin lymphoma,"BIRMANN, BRENDA",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$577,153"
Lymphoma,2014,NCI,5R01CA151899-04,,Communication Skills Intervention to Promote Transition into Survivorship,"HORWITZ, STEVEN",SLOAN-KETTERING INST CAN RESEARCH,NY,"$574,569"
Lymphoma,2014,NCI,5P01CA015396-39,5878,Targeting Cancer Stem Cells,"JONES, RICHARD",JOHNS HOPKINS UNIVERSITY,MD,"$333,103"
Lymphoma,2014,NCI,5F31CA180451-02,,Temporal regulation of the essential Epstein-Barr virus oncoprotein LMP1,"PRICE, ALEXANDER",DUKE UNIVERSITY,NC,"$32,945"
Lymphoma,2014,NHLBI,5F32HL117581-02,,Mechanisms of Lkb1 function in lymphocytes in the context of Kras activation,"SOUROULLAS, GEORGE",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$55,094"
Lymphoma,2014,NCI,5P01CA148600-04,5304,CD19-Specific CB T-cell Therapy for Patients with B-cell Malignancies,"DOTTI, GIANPIETRO",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$153,538"
Lymphoma,2014,NCI,5P01CA148600-04,5309,Molecular Imaging Core,"GELOVANI, JURI",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$89,122"
Lymphoma,2014,NCI,5P01CA095426-13,5850,Innate Immune Therapy for B-Cell Malignancies,"BYRD, JOHN",OHIO STATE UNIVERSITY,OH,"$370,509"
Lymphoma,2014,NCI,5P01CA095426-13,5857,MOUSE MODELING AND ANIMAL DEVELOPMENT,"MUTHUSAMY, NATARAJAN",OHIO STATE UNIVERSITY,OH,"$239,944"
Lymphoma,2014,NCI,5P50CA107399-09,5351,CD19-Specific Central Memory T Cell Adoptive Immunotherapy for Non-Hodgkin Lymphoma,"RAUBITSCHEK, ANDREW",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$1,027,402"
Lymphoma,2014,NCI,5P50CA107399-09,5352,Adoptive T Cell Therapy For Non-Hodgkin Lymphoma,"JENSEN, MICHAEL",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$170,695"
Lymphoma,2014,NCI,5P50CA107399-09,5354,Humanized Anti-CD20-IL2 for the Treatment of CD20 Positive Lymphomas,"RAUBITSCHEK, ANDREW",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$222,249"
Lymphoma,2014,NCI,5P50CA107399-09,5353,Therapy-Related Leukemia Following Autologous Transplantation for Lymphoma,"BHATIA, RAVI",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$179,611"
Lymphoma,2014,NCI,5P50CA107399-09,5356,Administrative Core,"FORMAN, STEPHEN",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$138,622"
Lymphoma,2014,NCI,5P50CA107399-09,5357,Biostatistics and Research Informatics,"NILAND, JOYCE",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$40,784"
Lymphoma,2014,NCI,5P50CA107399-09,5358,Tissue Bank for Cellular and Molecular Studies,"WEISS, LAWRENCE",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$82,882"
Lymphoma,2014,NCI,5P50CA107399-09,5359,Biologics Manufacturing Core,"COLCHER, DAVID",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$214,074"
Lymphoma,2014,NCI,5P50CA107399-09,5360,Developmental Research Program,"FORMAN, STEPHEN",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$42,841"
Lymphoma,2014,NCI,5P50CA107399-09,5361,Career Development Program,"FORMAN, STEPHEN",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$42,841"
Lymphoma,2014,NCI,1R01CA180813-01A1,,Kaposi's Sarcoma-associated Herpesvirus Mimics of Cellular microRNAs,"GOTTWEIN, EVA",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$320,588"
Lymphoma,2014,NCI,7P01CA090890-10,6522,Transplacental Chemoprevention of Lung Tumors and Lymphomas,"WILLIAMS, DAVID",OREGON STATE UNIVERSITY,OR,"$260,425"
Lymphoma,2014,NCI,5P01CA081534-14,6644,Molecular Genetics,"CROCE, CARLO",OHIO STATE UNIVERSITY,OH,"$528,163"
Lymphoma,2014,NCI,5P01CA081534-14,6645,Molecular Inhibition of Apoptosis Inhibitors,"REED, JOHN",SANFORD-BURNHAM MEDICAL RESEARCH INSTIT,CA,"$449,324"
Lymphoma,2014,NCI,5P01CA081534-14,6646,Immune Therapy,"KIPPS, THOMAS",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$239,121"
Lymphoma,2014,NCI,5P01CA081534-14,6647,Immune Tolerance and Stem Cell Transplantation,"GRIBBEN, JOHN",BARTS AND THE LONDON SCHOOL OF MEDICINE,,"$239,893"
Lymphoma,2014,NCI,5P01CA081534-14,6648,Mechanism-Based Pharmacologic Intervention,"PLUNKETT, WILLIAM",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$143,443"
Lymphoma,2014,NCI,5P01CA081534-14,6649,Pharmacologic Inhibitors of Cellular Kinases and Signal Transduction,"GREVER, MICHAEL",OHIO STATE UNIVERSITY,OH,"$222,741"
Lymphoma,2014,NCI,5P01CA081534-14,6650,Administrative and Informatics,"KIPPS, THOMAS",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$604,294"
Lymphoma,2014,NCI,5P01CA081534-14,6651,Biostatistics,"NEUBERG, DONNA",DANA-FARBER CANCER INST,MA,"$173,360"
Lymphoma,2014,NCI,5P01CA081534-14,6652,Tissue Core,"RASSENTI, LAURA",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$538,699"
Lymphoma,2014,NCI,5P01CA081534-14,6653,Clinical Program,"WIERDA, WILLIAM",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$630,885"
Lymphoma,2014,NCI,5P01CA018029-39,5850,Nonmyeloablative Hematopoietic Cell Allotransplants,"STORB, RAINER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$324,112"
Lymphoma,2014,NCI,5R00CA140728-05,,Immunotransplant to Mantle Cell Lymphoma: Immune Response and Clinical Outcomes,"BRODY, JOSHUA",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$241,530"
Lymphoma,2014,NIDCR,5DP5OD012160-04,,Detection of Chromosomal Translocations by Single Molecule RNA Imaging,"BATISH, MONA",RBHS-NEW JERSEY MEDICAL SCHOOL,NJ,$1
Lymphoma,2014,RMAP,5DP5OD012160-04,,Detection of Chromosomal Translocations by Single Molecule RNA Imaging,"BATISH, MONA",RBHS-NEW JERSEY MEDICAL SCHOOL,NJ,"$459,980"
Lymphoma,2014,NCI,5R01CA161151-02,,Lig4R278H contribution to HSC and IgH class switching defects and malignancies,"YAN, CATHERINE",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$357,586"
Lymphoma,2014,NCI,5R01CA163910-02,,TARGETING ANTIGEN-INDUCED ER STRESS RESPONSE IN B-CELL CHRONIC LYMPHOCYTIC LEUKEM,"HU, CHIH-CHI",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$339,148"
Lymphoma,2014,NCI,5K23CA178183-02,,Targeted Therapies and Mechanisms of Resistance in Chronic Lymphocytic Leukemia,"WOYACH, JENNIFER",OHIO STATE UNIVERSITY,OH,"$173,232"
Lymphoma,2014,NCI,5U01CA121947-08,6759,UCLA-USC Combined Los Angeles Core Site,"MITSUYASU, RONALD",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$166,391"
Lymphoma,2014,NCI,5U01CA121947-08,6760,UCSD Core Site,"WACHSMAN, WILLIAM",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$166,393"
Lymphoma,2014,NCI,5U01CA121947-08,6761,UCSF Core Site,"KAPLAN, LAWRENCE","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$166,391"
Lymphoma,2014,NCI,5P01CA023766-35,6334,Clinical Trials Evaluating Transplant Strategies and Adoptive Cell Therapies to,"O'REILLY, RICHARD",SLOAN-KETTERING INST FOR CANCER RES,,"$420,112"
Lymphoma,2014,NCI,2P01CA100730-11A1,5163,Core C: Animal Models,"NIEWIESK, STEFAN",OHIO STATE UNIVERSITY,OH,"$291,352"
Lymphoma,2014,NCI,2P01CA100730-11A1,5166,Project 3: Effect of HTLV-1 Viral Oncogenes on the Bone Microenvironment in ATL,"WEILBAECHER, KATHERINE",OHIO STATE UNIVERSITY,OH,"$298,881"
Lymphoma,2014,NCI,2P01CA100730-11A1,5167,Project 4: Tumorigenic Effects of Tax,"RATNER, LEE",OHIO STATE UNIVERSITY,OH,"$419,534"
Lymphoma,2014,NCI,2P01CA078902-16,5395,Project 3: Stem Cell Allografts for Lymphoid Malignancies,"MALONEY, DAVID",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$263,671"
Lymphoma,2014,NCI,5R01CA130995-07,,"Replication Licensing in Genome Stability, Cancer and Aging","PRUITT, STEVEN",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$315,001"
Lymphoma,2014,NCI,5R01CA182736-02,,MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL,"GRAY, NATHANAEL",DANA-FARBER CANCER INST,MA,"$684,151"
Lymphoma,2014,NCI,5P01CA049605-25,5891,Immune Regulation in HCT,"NEGRIN, ROBERT",STANFORD UNIVERSITY,CA,"$1,117,156"
Lymphoma,2014,NCI,5P01CA049605-25,5892,Auto-lmmunotransplantation for Lymphoma,"LEVY, RONALD",STANFORD UNIVERSITY,CA,"$193,544"
Lymphoma,2014,NCI,5P01CA049605-25,5893,Memory CDS T Cells for GVL,"STROBER, SAMUEL",STANFORD UNIVERSITY,CA,"$146,013"
Lymphoma,2014,NCI,5P01CA049605-25,5894,Improving Graft-versus-Leukemia Alloimmunity against CLL,"MIKLOS, DAVID",STANFORD UNIVERSITY,CA,"$131,702"
Lymphoma,2014,NCI,5P01CA049605-25,5897,Administration and Clinical Trial Coordination,"NEGRIN, ROBERT",STANFORD UNIVERSITY,CA,"$250,980"
Lymphoma,2014,NCI,5P01CA049605-25,5898,Biostatistics and Data Management,"LAVORI, PHILIP",STANFORD UNIVERSITY,CA,"$181,385"
Lymphoma,2014,NCI,5P01CA049605-25,5899,Molecular Diagnostics,"ZEHNDER, JAMES",STANFORD UNIVERSITY,CA,"$232,274"
Lymphoma,2014,NCI,5P01CA049605-25,5900,Cell Processing and Sample Distribution Laboratory,"LOWSKY, ROBERT",STANFORD UNIVERSITY,CA,"$365,947"
Lymphoma,2014,NCI,3R41CA162587-01A1S1,,"Diagnosis, Prognosis and Treatment of hRgr associated Hematopoietic Malignancies","LEONARDI, PETER",OMNICYTE,NY,"$173,412"
Lymphoma,2014,NCI,1R01CA187040-01,,Targeting SIRT1 in Mantle Cell Lymphoma,"SETO, EDWARD",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$349,638"
Lymphoma,2014,NIGMS,1R01GM112192-01,,Enhancer Driven Gene Regulation During Lymphocyte Development,"SKOK, JANE",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$525,166"
Lymphoma,2014,NCI,1R01CA187109-01,,Targeting EZH2 in Germinal Center Derived B-Cell Lymphoma,"MELNICK, ARI",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$396,457"
Lymphoma,2014,NCI,5F31CA180449-02,,EBV-mediated carcinogenesis in AIDS-associated Diffuse Large B Cell Lymphoma,"O'GRADY, CHRISTINA",TULANE UNIVERSITY OF LOUISIANA,LA,"$40,755"
Lymphoma,2014,NIAID,1R01AI106676-01A1,,Epstein Barr virus antisense transcription,"FLEMINGTON, ERIK",TULANE UNIVERSITY OF LOUISIANA,LA,"$376,250"
Lymphoma,2014,NCI,1R01CA187492-01,,MALT1 Targeted Therapy for B-Cell Lymphoma,"MELNICK, ARI",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$351,713"
Lymphoma,2014,NCI,5F30CA177173-02,,Role of Shcbp1 (mPAL) in T Cell Development and Function,"BUCKLEY, MONICA",UNIVERSITY OF VIRGINIA,VA,"$29,732"
Lymphoma,2014,NCI,2P30CA013696-40,6105,Lymphoid Development and Malignancy Program,"EMERSON, STEPHEN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$33,320"
Lymphoma,2014,NCI,2P30CA013696-40,6127,Recruitment,"EMERSON, STEPHEN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$90,518"
Lymphoma,2014,NCI,1R21CA181997-01A1,,Novel role of SAMHD1 as a tumor suppressor in cutaneous T-cell lymphomas,"WU, LI",OHIO STATE UNIVERSITY,OH,"$167,475"
Lymphoma,2014,NCI,5P01CA174439-02,8216,Role of LANA-RBP-jk During Early KSHV Infection,"ROBERTSON, ERLE",UNIVERSITY OF PENNSYLVANIA,PA,"$374,854"
Lymphoma,2014,NCI,5P01CA174439-02,8218,Chromatin Regulation of KSHV Primary Infection,"LIEBERMAN, PAUL",WISTAR INSTITUTE,PA,"$390,256"
Lymphoma,2014,NCI,5P01CA165997-02,8409,Micro-RNA-dependent regulation of the UPR,"DIEHL, JOHN",UNIVERSITY OF PENNSYLVANIA,PA,"$303,419"
Lymphoma,2014,NCI,5P01CA165997-02,8411,Role of the UPR in myc-induced tumorigenesis,"KOUMENIS, CONSTANTINOS",UNIVERSITY OF PENNSYLVANIA,PA,"$257,977"
Lymphoma,2014,NCI,5P01CA165997-02,8412,"UPR, interferon signaling and tumorigenesis","FUCHS, SERGE",UNIVERSITY OF PENNSYLVANIA,PA,"$300,424"
Lymphoma,2014,NCI,1R01CA188005-01,,Therapeutic In Situ Vaccination for Human Lymphoma,"LEVY, RONALD",STANFORD UNIVERSITY,CA,"$311,682"
Lymphoma,2014,NIAID,1R21AI113033-01,,Novel regulatory regions within the immunoglobulin kappa locus,"FEENEY, ANN",SCRIPPS RESEARCH INSTITUTE,CA,"$284,250"
Lymphoma,2014,NCI,5P01CA180779-02,8776,Core Director: Hye-Ra-Lee,"JUNG, JAE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$102,714"
Lymphoma,2014,NCI,1R03CA187854-01,,Impact of Short Inverted Repeats on Genetic Instability at Mutation Hotspots,"VASQUEZ, KAREN","UNIVERSITY OF TEXAS, AUSTIN",TX,"$77,250"
Lymphoma,2014,NCI,2R01CA134451-05A1,,Computer-based assessment of tumor microenvironment (TME) in Follicular Lymphoma,"GURCAN, METIN",OHIO STATE UNIVERSITY,OH,"$325,384"
Lymphoma,2014,NCI,2R01CA076287-15,,Pretargeted Radioimmunotherapy of CD20+ Lymphomas,"PRESS, OLIVER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$405,431"
Lymphoma,2014,NCI,2R01CA139083-06A1,,Recognition and Targeting of CNS Lymphoma by Tumor-Associated Macrophages,"RUBENSTEIN, JAMES","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$384,229"
Lymphoma,2014,NCI,1R01CA181319-01A1,,Targeting Stem-Cell Dependent Drug Resistance in Human MCL,"MCCARTY, NAMI",UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,TX,"$313,723"
Lymphoma,2014,NCI,1R01CA181699-01A1,,Investigating the roles of lncRNAs in cancer and development,"VENTURA, ANDREA",SLOAN-KETTERING INST CAN RESEARCH,NY,"$432,404"
Lymphoma,2014,NCI,2R01CA136895-06A1,,Understanding the context-dependent roles of mutations in lymphoma.,"DAVE, SANDEEP",DUKE UNIVERSITY,NC,"$283,200"
Lymphoma,2014,NCI,1R01CA189806-01A1,,Impact of malaria on shaping immunity to EBV in the etiology of Burkitt lymphoma,"MOORMANN, ANN",UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,"$575,723"
Lymphoma,2014,NCI,1R01CA188794-01,,Cell cycle reprogramming for therapeutic targeting of BTK in lymphoma,"CHEN-KIANG, SELINA",WEILL MEDICAL COLL OF CORNELL UNIV,NY,"$351,713"
Lymphoma,2014,NCI,1R21CA188824-01,,Plasma and serum biomarkers for Hodgkin lymphoma,"AMBINDER, RICHARD",JOHNS HOPKINS UNIVERSITY,MD,"$241,714"
Lymphoma,2014,NCI,1R03CA188614-01,,Risk of hematologic cancers from repeated low-dose diagnostic radiation,"ZABLOTSKA, LYDIA","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$79,042"
Lymphoma,2014,NCI,3R01CA168482-02S1,,HIV driven B cell activation: role in the genesis of AIDS-related lymphoma,"MARTINEZ-MAZA, OTONIEL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$93,771"
Lymphoma,2014,NCI,2R44CA159843-02,,A new small molecule targeting agent and therapeutic for non-Hodgkin's lymphoma,"BALHORN, RODNEY","SHAL TECHNOLOGIES, INC.",CA,"$748,921"
Lymphoma,2014,NCI,1F30CA189433-01,,Investigating the function of MTBP in lymphoma,"PUCCETTI, MATTHEW",VANDERBILT UNIVERSITY,TN,"$27,334"
Lymphoma,2014,NIAID,2R44AI096588-03,,Development of a Small Molecule Inhibitor for EBV Latent Infection,"VAN DEN HEUVEL, PIETER","VIRONIKA, LLC",PA,"$750,000"
Lymphoma,2014,NCI,2R44CA168019-02A1,,Automated Ultrasensitive Detection of Light Chain Restriction in Lymphoproliferat,"MA, XIAO-JUN","ADVANCED CELL DIAGNOSTICS, INC.",CA,"$834,236"
Lymphoma,2014,NCI,1F31CA183504-01A1,,Non-catalytic functions of DNA-PK in DNA repair and tumorigenesis,"CROWE, JENNIFER",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$42,676"
Lymphoma,2014,NCI,1F32CA183381-01A1,,c-MYC dependent regulation of de novo lipogenesis in B-cell lymphomagenesis,"SCOTT, KRISTEN",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$53,282"
Lymphoma,2014,NCI,2R01CA085533-11A1,,Regulation of p53 acetylation and deacetylation in tumorigenesis,"GU, WEI",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$288,000"
Lymphoma,2014,NCI,1F30CA189740-01,,Alternative End-Joining in DNA Repair and Chromosomal Translocations,"KUMAR, VIPUL",HARVARD MEDICAL SCHOOL,MA,"$34,970"
Lymphoma,2014,NCI,4R00CA151827-03,,Role of Replication Stress during Myc-dependent Lymphomagenesis,"DOMINGUEZ-SOLA, DAVID",ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,NY,"$224,101"
Lymphoma,2014,NCI,4R00CA166181-02,,Specificity of the Ubiquitin System in Lymphoid Malignancies,"BUSINO, LUCA",UNIVERSITY OF PENNSYLVANIA,PA,"$224,099"
Lymphoma,2014,NIAID,7R01AI083453-06,,The NF-kB signaling system as a regulator of B-cell activation,"HOFFMANN, ALEXANDER",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$283,268"
Lymphoma,2014,NCI,2R01CA073507-16,,In Vivo Model of Epstein-Barr Virus Latency,"LONGNECKER, RICHARD",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$372,677"
Lymphoma,2014,NIDCR,1R21DE024703-01,,Histone variant H3.3 and KSHV LANA in the pathogenesis of oral Kaposi's sarcoma,"RENNE, ROLF",UNIVERSITY OF FLORIDA,FL,"$223,587"
Lymphoma,2014,NCI,2R42CA183708-03A1,,An Early-Phase Clinical Trial Evaluating ABC294640 in Patients with Refractory/Re,"PARSONS, CHRISTOPHER",APOGEE BIOTECHNOLOGY CORPORATION,PA,"$509,024"
Lymphoma,2014,NCI,3P30CA124435-08S1,,Stanford University Cancer Center,"MITCHELL, BEVERLY",STANFORD UNIVERSITY,CA,"$75,000"
Lymphoma,2014,NCI,1K99CA183914-01A1,,A Novel Oncogenic Role for Cdc20 Implications in Adult T Cell Leukemia Treatment,"WAN, LIXIN",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$169,668"
Lymphoma,2014,NCI,3R01CA140963-05S1,,Cell Cycle Regulation and Adult T Cell Leukemia,"GIAM, CHOU-ZEN",HENRY M. JACKSON FDN FOR THE ADV MIL/MED,MD,"$19,772"
Lymphoma,2014,NCI,3R01CA160256-03S1,,Temporal and Spatial Control of V(D)J Recombination,"DESIDERIO, STEPHEN",JOHNS HOPKINS UNIVERSITY,MD,"$51,299"
Lymphoma,2014,NIGMS,3R01GM103843-02S1,,Dissecting Cell Signaling Mediated by Protein-Protein Interactions in Membranes,"YIN, HANG",UNIVERSITY OF COLORADO,CO,"$67,100"
Lymphoma,2014,NCI,1R01CA190696-01,,A New Treatment Paradigm for ALK-Driven Cancers Exploiting Oncogene Overdose,"SCHATZ, JONATHAN",UNIVERSITY OF ARIZONA,AZ,"$316,610"
Lymphoma,2014,NCI,1K99CA190861-01,,Chemical Modulation of Chromatin Signaling in Lymphoid Malignancies,"OTT, CHRISTOPHER",DANA-FARBER CANCER INST,MA,"$98,107"
Lymphoma,2014,NIAID,2R01AI045073-16A1,,Chemokines and Lymphoid Tissue Organization and Function,"CYSTER, JASON","UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",CA,"$355,688"
Lymphoma,2014,NCI,3R01CA154674-04S1,,Cotranslational functions of mTOR,"JACINTO, ESTELA",RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL,NJ,"$53,868"
Lymphoma,2014,NCI,3R01CA166325-03S1,,Mechanisms promoting translocations and mature B cell lymphomas,"WANG, JING",UNIVERSITY OF COLORADO DENVER,CO,"$54,081"
Lymphoma,2014,NCI,2R01CA136551-06A1,,Targeted therapy of B cell malignances with CAR-T cells of defined composition,"RIDDELL, STANLEY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$579,424"
Lymphoma,2014,RMAP,1K01ES025431-01,,The role of epigenetic heterogeneity in CLL evolution,"LANDAU, DAN",DANA-FARBER CANCER INST,MA,"$187,424"
Lymphoma,2014,NCATS,2R42CA173900-02,,Targeting B-cell lymphoma with Leukothera-phase II,"BELINKA, BENJAMIN","ACTINOBAC BIOMED, INC.",NJ,"$38,487"
Lymphoma,2014,NCI,2R42CA173900-02,,Targeting B-cell lymphoma with Leukothera-phase II,"BELINKA, BENJAMIN","ACTINOBAC BIOMED, INC.",NJ,"$866,553"
Lymphoma,2014,NCI,3R01CA155010-04S1,,Personal tumor neoantigens for immunity against chronic lymphocytic leukemia,"WU, CATHERINE",DANA-FARBER CANCER INST,MA,"$288,332"
Lymphoma,2014,RMAP,3R01CA166450-02S1,,Characterizing tumor suppressive functions of microRNAs in B-cell neoplasia,"RAO, DINESH",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$128,333"
Lymphoma,2014,NCI,2R13CA124293-08,,Annual International Primary CNS Lymphoma Collaborative Group Meeting,"BATCHELOR, TRACY",MASSACHUSETTS GENERAL HOSPITAL,MA,"$5,000"
Lymphoma,2014,RMAP,3DP5OD012160-03S1,,Detection of Chromosomal Translocations by Single Molecule RNA Imaging,"BATISH, MONA",RBHS-NEW JERSEY MEDICAL SCHOOL,NJ,"$26,656"
Lymphoma,2014,NIAID,1R21AI116205-01,,"Targeting latent HIV-1 Reservoirs with the Antibody-Drug Conjugate, Brentuximab Vedotin","HENRICH, TIMOTHY",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$224,439"
Lymphoma,2014,NCI,3R01CA140337-04S1,,Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation,"LUFTIG, MICAH",DUKE UNIVERSITY,NC,"$60,427"
Lymphoma,2014,NCI,3R01CA180150-02S1,,(PQD1) Treatment-emergent resistance to NEDD8-activating enzyme inhibition,"PETROSKI, MATTHEW",SANFORD-BURNHAM MEDICAL RESEARCH INSTIT,CA,"$108,952"
Lymphoma,2014,NCI,261200800001E-66-0-35,,Genotyping for epidemiology studies,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",,"$7,245,137"
Lymphoma,2014,NCI,261200800001E-66-0-36,,Repository Services for epidemiology studies,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",,"$1,671,271"
Lymphoma,2014,NCI,261200800001E-66-0-51,,DCTD Biopharmaceutical Development,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",,"$5,333,006"
Lymphoma,2014,NIDDK,261200800001E-66-0-52,,DCTD Biopharmaceutical Development - Type 1 Diabetes RAID projects,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",,"$107,834"
Lymphoma,2014,NCI,261200800001E-66-0-105,,OCG Web Transition and Development,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",,"$35,000"
Lymphoma,2014,NCI,3P01CA119070-08S1,,Oncogenic Notch Signaling,"ASTER, JON",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$56,850"
Lymphoma,2014,NIAID,1R56AI113130-01,,New Therapeutics for Post-Transplant Lymphoproliferative Disorder,"MARTINEZ, OLIVIA",STANFORD UNIVERSITY,CA,"$402,265"
Lymphoma,2014,NCI,3P30CA023074-35S2,,Arizona Cancer Center-Cancer Center Support Grant,"CRESS, ANNE",UNIVERSITY OF ARIZONA,AZ,"$3,835,199"
Lymphoma,2014,NCI,7R01CA167093-04,,Myc-directed control of mRNA turnover in lymphopoiesis and lymphomagenesis,"CLEVELAND, JOHN",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$13,374"
Lymphoma,2014,NCI,7R01CA093237-13,,Nuclear Accumulation of Cyclin D1 and Oncogenesis,"DIEHL, JOHN",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$269,783"
Lymphoma,2014,NCI,3P30CA124435-08S2,,Stanford University Cancer Center,"MITCHELL, BEVERLY",STANFORD UNIVERSITY,CA,"$323,044"
Lymphoma,2014,FIC,1U54CA190146-01,6249,Project 2,"CASPER, COREY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$6,433"
Lymphoma,2014,NCI,1U54CA190146-01,6249,Project 2,"CASPER, COREY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$90,055"
Lymphoma,2014,NCI,3P30CA023074-35S3,,Arizona Cancer Center-Cancer Center Support Grant,"CRESS, ANNE",UNIVERSITY OF ARIZONA,AZ,"$75,000"
Lymphoma,2014,NCI,3P30CA023074-35S4,,Arizona Cancer Center-Cancer Center Support Grant,"CRESS, ANNE",UNIVERSITY OF ARIZONA,AZ,"$50,000"
Lymphoma,2014,NCI,261201300021I-0-26100004-1,,Patterns of Care/Quality of Care Study: Diagnosis Year 2013 (SEER) Period of Performance: 08/15/2014 - 08/14/2015,"STROUP, PHD, ANTOINETTE",RBHS -CANCER INSTITUTE OF NEW JERSEY,NJ,"$126,463"
Lymphoma,2014,NCI,261201300020I-0-26100004-1,,Patterns of Care/Quality of Care Study: Diagnosis Year 2013 (SEER) Period of Performance: 08/15/2014 - 08/14/2015,"LYNCH, CHARLES",UNIVERSITY OF IOWA,IA,"$47,370"
Lymphoma,2014,NCI,261201300019I-0-26100004-1,,Patterns of Care/Quality of Care Study: Diagnosis Year 2013 (SEER)Period of Performance: 08/15/2014-08/14/2015,"PHILLIPS, CATHRYN",CONNECTICUT STATE DEPT OF PUBLIC HEALTH,CT,"$49,740"
Lymphoma,2014,NCI,261201300017I-0-26100004-1,,Patterns of Care/Quality of Care Study: Diagnosis Year 2013 SEER) HHSN261201300017I - University of Utah; POP 08/15/2014 - 08/14/2015 TO# HHSN261200004,"SWEENEY, CAROL",UNIVERSITY OF UTAH,UT,"$32,381"
Lymphoma,2014,NCI,261201300016I-0-26100004-1,,Patterns of Care/Quality of Care: Diagnosis Year 2013 (SEER)POP 08/15/2014 - 08/14/2015Line item#: 1,"WU, XIAO-CHENG",LSU HEALTH SCIENCES CENTER,LA,"$63,133"
Lymphoma,2014,NCI,4R00CA157954-03,,Convergence of CREB and MYC Pathways in Oncogenesis.,"AMELIO, ANTONIO",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$241,531"
Lymphoma,2014,NCI,261201300015I-0-26100005-1,,"Patterns of Care/Quality of Care Study: Diagnosis Year 2013SEER) HHSN261201300015I - Emory University POP 08/15/2014 -08/14/2015, TO# HHNS261200005","WARD, KEVIN",EMORY UNIVERSITY,GA,"$41,502"
Lymphoma,2014,NCI,261201300014I-0-26100004-1,,DescriptionPatterns of Care/Quality of Care Study: Diagnosis Year 2013 (SEER)Period of Performance: 08/15/2014-08/14/2015Line item #: 1,"WEST, DEE",PUBLIC HEALTH INSTITUTE,CA,"$164,870"
Lymphoma,2014,NCI,261201300013I-0-26100004-1,,Patterns of Care/Quality of Care Study: Diagnosis Year 2013 (SEER)Period of Performance: 08/15/2014-08/14/2015Line item #: 1,"TUCKER, THOMAS",UNIVERSITY OF KENTUCKY,KY,"$116,712"
Lymphoma,2014,NCI,261201300012I-0-26100004-1,,Patterns of Care/Quality of Care Study: Diagnosis Year 2013 (SEER)Period of Performance: 08/15/2014-08/14/2015Line item #: 1,"SCHWARTZ, STEPHEN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$67,568"
Lymphoma,2014,NCI,261201300011I-0-26100004-1,,Patterns of Care/Quality of Care Study: Diagnosis Year 2013 (SEER)Period of Performance: 08/15/2014-08/14/2015Line item #: 1,"KATO, IKUKO",WAYNE STATE UNIVERSITY,MI,"$94,763"
Lymphoma,2014,NCI,261201300010I-0-26100004-1,,Patterns of Care/Quality of Care Study: Diagnosis Year 2013 (SEER) Period of Performance: 08/15/2014 - 08/14/2015,"WIGGINS, CHARLES",UNIVERSITY OF NEW MEXICO,NM,"$28,121"
Lymphoma,2014,NCI,261201300009I-0-26100004-1,,Patterns of Care/Quality of Care Study: Diagnosis Year 2013 (SEER) Period of Performance: 08/15/2014 - 08/14/2015,"HERNANDEZ, PH.D., BRENDA",HAWAII UNIV,HI,"$47,038"
Lymphoma,2014,NCI,261201300005I-0-26100005-1,,Patterns of Care/Quality of Care Study: Diagnosis Year 2013 (SEER) Period of Performance: 08/15/2014 - 08/14/2015,"KEEGAN, THERESA",CANCER PREVENTION INSTIT OF CALIFORNIA,CA,"$141,817"
Lymphoma,2014,NCI,261201300004I-0-26100004-1,,Patterns of Care/Quality of Care Study: Diagnosis Year 2013 (SEER) Period of Performance: 08/15/2014 - 08/14/2015,"HAMILTON, ANN",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$130,786"
Lymphoma,2014,NIA,1ZIAAG000777-03,,Effect of Age on Antibody Diversity,"GEARHART, PATRICIA",NIH,,"$1,024,050"
Lymphoma,2014,NCI,2P01CA078902-16,7384,Program Integration and management,"STORB, RAINER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$19,085"
Lymphoma,2014,FIC,1U54CA190152-01,7397,Project 2,"GOPAL, SATISH",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$12,663"
Lymphoma,2014,NCI,1U54CA190152-01,7397,Project 2,"GOPAL, SATISH",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$176,754"
Lymphoma,2014,FIC,1U54CA190152-01,7398,Project 3,"GOPAL, SATISH",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$10,970"
Lymphoma,2014,NCI,1U54CA190152-01,7398,Project 3,"GOPAL, SATISH",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$153,129"
Lymphoma,2014,NCI,5P01CA094237-12,7520,VACCINATION TO ENHANCE T CELL IMMUNOTHERAPY,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$282,534"
Lymphoma,2014,NCI,5P01CA094237-12,7522,ENGINEERING T CELLS FOR PANCREATIC CANCER,"HESLOP, HELEN",BAYLOR COLLEGE OF MEDICINE,TX,"$247,486"
Lymphoma,2014,NCI,2P30CA008748-48,7551,Monoclonal Antibody,"WEIS-GARCIA, FRANCES",SLOAN-KETTERING INST CAN RESEARCH,NY,"$282,755"
Lymphoma,2014,NCI,1ZIABC008753-32,,Immunotoxin Therapy of Solid and Hematopoietic Tumors:  Preclinical Studies,"PASTAN, IRA",NIH,,"$2,511,684"
Lymphoma,2014,NCI,1ZIABC009287-30,,Cytokines and T Cell Development,"DURUM, SCOTT",NIH,,"$631,357"
Lymphoma,2014,NCI,1ZIABC009405-20,,Regulation of Lymphocyte Proliferation and Replicative Capacity,"HODES, RICHARD",NIH,,"$306,017"
Lymphoma,2014,NCI,1ZIABC010008-19,,The Genetics of Susceptibility to Mouse Plasma Cell Tumors,"MOCK, BEVERLY",NIH,,"$418,140"
Lymphoma,2014,NCI,1ZIABC010283-17,,DNA Repair,"NUSSENZWEIG, ANDRE",NIH,,"$1,363,940"
Lymphoma,2014,NCI,1ZIABC010301-17,,Development of Recombinant Toxins to Treat Hematologic Malignancies,"KREITMAN, ROBERT",NIH,,"$1,241,003"
Lymphoma,2014,NCI,1ZIABC010304-16,,Biochemical Basis of T Cell Activation,"SAMELSON, LAWRENCE",NIH,,"$1,990,130"
Lymphoma,2014,NCI,1ZIABC010621-11,,Translational Studies of the Histone Deacetylase Inhibitor Romidepsin,"BATES, SUSAN",NIH,,"$1,002,877"
Lymphoma,2014,NCI,1ZIABC010717-09,,Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,"WILSON, WYNDHAM",NIH,,"$140,872"
Lymphoma,2014,NCI,1ZIABC010719-09,,Randomized Phase II study of borteozmibEPOCH-R in Mantle cell lymphoma,"WILSON, WYNDHAM",NIH,,"$140,872"
Lymphoma,2014,NCI,1ZIABC010728-09,,Phase III Study of R-CHOP v DA-EPOCH-R with microarray,"WILSON, WYNDHAM",NIH,,"$281,743"
Lymphoma,2014,NCI,1ZIABC010747-09,,Characterization of the Expression and Ligands of KIR3DS1,"MCVICAR, DANIEL",NIH,,"$156,915"
Lymphoma,2014,NCI,1ZIABC010779-08,,Regulation and Consequences of Ubiquitination,"ASHWELL, JONATHAN",NIH,,"$319,675"
Lymphoma,2014,NCI,1ZIABC010885-07,,Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies,"YARCHOAN, ROBERT",NIH,,"$813,621"
Lymphoma,2014,NCI,1ZIABC010888-07,,Clinical Trials of Patients with AIDS-Related Malignancies,"YARCHOAN, ROBERT",NIH,,"$1,118,728"
Lymphoma,2014,NCI,1ZIABC010957-07,,Transplant Models,"GRESS, RONALD",NIH,,"$1,380,789"
Lymphoma,2014,NCI,1ZIABC010982-07,,Collaborative Pathways that Lead to Leukemia,"APLAN, PETER",NIH,,"$273,170"
Lymphoma,2014,NCI,1ZIABC011006-07,,Molecular diagnosis and outcome prediction in lymphoma,"STAUDT, LOUIS",NIH,,"$1,263,868"
Lymphoma,2014,NCI,1ZIABC011007-07,,RNA interference-based screens for molecular targets in cancer,"STAUDT, LOUIS",NIH,,"$1,263,868"
Lymphoma,2014,NCI,1ZIABC011008-07,,Oncogenic mechanisms and molecular targets in lymphoma,"STAUDT, LOUIS",NIH,,"$1,263,868"
Lymphoma,2014,NCI,1ZIABC011010-07,,Oncogenic mechanisms and molecular targets in myeloma,"STAUDT, LOUIS",NIH,,"$1,263,868"
Lymphoma,2014,NCI,1ZIABC011064-07,,A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1,"MOCK, BEVERLY",NIH,,"$156,802"
Lymphoma,2014,NCI,1ZIABC011065-07,,Preclinical Testing of HDAC and mTOR Inhibitors,"MOCK, BEVERLY",NIH,,"$470,407"
Lymphoma,2014,NCI,1ZIABC011070-07,,Hematopathology Diagnosis,"JAFFE, ELAINE",NIH,,"$612,191"
Lymphoma,2014,NCI,1ZIABC011192-06,,The Mechanism of Thymic Lymphomagenesis in Genetically Engineered Mouse Model,"VAN DYKE, TERRY",NIH,,"$56,066"
Lymphoma,2014,NCI,1ZIABC011219-06,,Combination Gene Therapy and Th1Th2 Therapy,"FOWLER, DANIEL",NIH,,"$383,001"
Lymphoma,2014,NCI,1ZIABC011354-05,,BCR Signaling in ABC DLBCL,"WILSON, WYNDHAM",NIH,,"$140,872"
Lymphoma,2014,NCI,1ZIABC011374-04,,Allotransplant for DOCK8 deficiency,"HICKSTEIN, DENNIS",NIH,,"$394,106"
Lymphoma,2014,NCI,1ZIABC011413-04,,Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor,"KOCHENDERFER, JAMES",NIH,,"$150,144"
Lymphoma,2014,NCI,1ZIABC011415-04,,Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor,"KOCHENDERFER, JAMES",NIH,,"$300,287"
Lymphoma,2014,NCI,1ZIABC011417-04,,New Chimeric Antigen Receptors for Treating Hematologic Malignancies,"KOCHENDERFER, JAMES",NIH,,"$600,576"
Lymphoma,2014,NCI,1ZIABC011471-03,,Cell-free assay technologies for the identification of active compounds,"OKEEFE, BARRY",NIH,,"$887,458"
Lymphoma,2014,NCI,1ZIABC011511-02,,Chemical Targeting of Multi-Protein Complexes,"BERNAL, FEDERICO",NIH,,"$139,421"
Lymphoma,2014,NCI,1ZIACP004410-38,,Family Studies,"TUCKER, MARGARET",NIH,,"$3,587,371"
Lymphoma,2014,NCI,1ZIACP005782-20,,Epidemiology of Oncogenic Viruses,"O'BRIEN, THOMAS",NIH,,"$436,348"
Lymphoma,2014,NCI,1ZIACP010125-19,,Cancer Risk and Environmental Exposures,"WARD, MARY",NIH,,"$1,210,402"
Lymphoma,2014,NCI,1ZIACP010131-19,,Studies of Populations Exposed to Therapeutic Medical Radiation and Other Agents,"BERRINGTON, AMY",NIH,,"$2,668,052"
Lymphoma,2014,NCI,1ZIACP010150-15,,"Infections, immunity, and inflammation in cancer","ENGELS, ERIC",NIH,,"$1,373,590"
Lymphoma,2014,NCI,1ZIACP010170-14,,Multidisciplinary Studies of Hematopoietic Malignancies,"MORTON, LINDSAY",NIH,,"$860,372"
Lymphoma,2014,NCI,1ZIACP010176-14,,Epidemiology and Natural History of Cancer-Associated Viruses,"MBULAITEYE, SAM",NIH,,"$3,379,228"
Lymphoma,2014,NCI,1ZIACP010212-05,,Molecular mechanisms of infection-related cancer,"RABKIN, CHARLES",NIH,,"$164,791"
Lymphoma,2014,NCI,1ZIACP010214-05,,Microbes and Human Malignancies,"GOEDERT, JAMES",NIH,,"$431,546"
Lymphoma,2014,NEI,1ZIAEY000222-29,,Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases,"CHAN, CHI-CHAO",NIH,,"$877,682"
Lymphoma,2014,NEI,1ZIAEY000356-14,,Diagnosis And Treatment Of Ocular Inflammatory Disease (uveitis),"NUSSENBLATT, ROBERT",NIH,,"$409,747"
Lymphoma,2014,NEI,1ZIAEY000375-14,,Primary Intraocular Lymphoma and Animal Models,"NUSSENBLATT, ROBERT",NIH,,"$41,217"
Lymphoma,2014,NCI,1ZIASC000550-34,,Lymphoma Disease Discovery and Definition,"JAFFE, ELAINE",NIH,,"$1,224,381"
Lymphoma,2014,NCI,1ZIASC006741-22,,Lymphoma Studies,"WILSON, WYNDHAM",NIH,,"$704,359"
Lymphoma,2014,NCI,1ZIASC010282-17,,Cytogenetic Studies of B-cell Chronic Lymphocytic Leukemia (B-CLL),"ARTHUR, DIANE",NIH,,"$109,174"
Lymphoma,2014,NCI,1ZIASC010288-17,,Th1Th2 and Tc1Tc2 T Cell Subsets in Transplantation Therapy,"FOWLER, DANIEL",NIH,,"$766,002"
Lymphoma,2014,NCI,1ZIASC010356-15,,A Role for KSHV in the Pathogenesis of Malignancies,"TOSATO, GIOVANNA",NIH,,"$323,585"
Lymphoma,2014,NCI,1ZIASC010357-15,,Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses,"ZHENG, ZHI-MING",NIH,,"$1,193,316"
Lymphoma,2014,NCI,1ZIASC010378-14,,Activation of Proto-Oncogenes by Chromosomal Translocation,"APLAN, PETER",NIH,,"$546,342"
Lymphoma,2014,NCI,1ZICBC011040-07,,Molecular Profiling of Clinical Specimens,"EDELMAN, DANIEL",NIH,,"$2,032,400"
Lymphoma,2014,NCI,1ZICBC011079-07,,Molecular Diagnostics Core Laboratory,"RAFFELD, MARK",NIH,,"$734,451"
Lymphoma,2014,NCI,1ZICBC011093-07,,Flow Cytometric Detection of Malignant Cells in Body Fluids,"STETLER-STEVENSON, MARYALICE",NIH,,"$240,469"
Lymphoma,2014,NCI,1ZIDBC010963-07,,ETIB Clinical Research Core,"GRESS, RONALD",NIH,,"$1,620,926"
Lymphoma,2014,NCI,1ZIDBC010990-07,,Radiation Oncology Branch - Radiation Clinic,"CAMPHAUSEN, KEVIN",NIH,,"$7,636,262"
Lymphoma,2014,NCI,1ZIDBC011539-01,,IL-15 in the immunotherapy of cancer,"CONLON, KEVIN",NIH,,"$1,026,376"
Lymphoma,2014,NCI,1ZIEBC010843-08,,Medical Oncology Fellowship Program,"GULLEY, JAMES",NIH,,"$6,360,176"
Lymphoma,2014,NCI,1ZIEBC011241-06,,Hematopathology Fellowship,"JAFFE, ELAINE",NIH,,"$612,191"
Lymphoma,2014,NCI,1ZIGBC010856-08,,Basic and Preclinical Animal Models in support of Cancer and HIVAIDS Research,"CUSTER, MARY",NIH,,"$21,080,166"
Lymphoma,2014,NIDDK,1ZIADK036167-08,,Structural studies of the post-cleavage complex in V(D)J recombination,"GELLERT, MARTIN",NIH,,"$907,777"
Lymphoma,2014,NHLBI,1ZIAHL002346-10,,"Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy","WIESTNER, ADRIAN",NIH,,"$1,276,483"
Lymphoma,2014,NHLBI,1ZIAHL005076-09,,"Novel therapies for Mantle Cell Lymphoma: targets, mechanisms, and prognosis","WIESTNER, ADRIAN",NIH,,"$425,494"
Lymphoma,2014,NHLBI,1ZIAHL006070-05,,Immunotherapy of low grade lymphoid malignancies,"WIESTNER, ADRIAN",NIH,,"$425,494"
Lymphoma,2014,NIAMS,1ZICAR041181-06,,Translational Immunology research: a support for clinical immunological research,"GADINA, MASSIMO",NIH,,"$1,945,727"
Lymphoma,2014,NIAID,1ZIAAI000565-18,,Regulation of SIGNALLING PATHWAYS INVOLVING NUCLEAR FACTOR KAPPA B,"LENARDO, MICHAEL",NIH,,"$278,878"
Lymphoma,2014,NIAID,1ZIAAI000732-20,,"Clinical, Immunological and Genetic  Analyses of ALPS","LENARDO, MICHAEL",NIH,,"$757,843"
Lymphoma,2014,NIAID,1ZIAAI000769-18,,Molecular Mechanisms Of The Autoimmune Lymphoproliferative Syndrome,"LENARDO, MICHAEL",NIH,,"$557,756"
Lymphoma,2014,NIAID,1ZIAAI000858-15,,Lymphomas And Retroviral Pathogenesis,"MORSE, HERBERT",NIH,,"$550,041"
Lymphoma,2014,NIAID,1ZIAAI000913-13,,Epstein-Barr Virus Associated Disorders,"COHEN, JEFFREY",NIH,,"$759,114"
Lymphoma,2014,NIAID,1ZIAAI000978-09,,Herpesvirus Pathogenesis and Vaccine Development,"COHEN, JEFFREY",NIH,,"$506,076"
Lymphoma,2014,NIAID,1ZIAAI001070-07,,Targeted Killing of Herpesvirus-Infected Cells and Ebola Virus-Infected Cells,"BERGER, EDWARD",NIH,,"$56,065"
Lymphoma,2014,NIAID,1ZIAAI001126-05,,B cell Receptor Dysregulation in Cancer and Autoimmune Disease,"PIERCE, SUSAN",NIH,,"$666,787"
Lymphoma,2014,NIAID,1ZIAAI001187-02,,New Roles of Magnesium as a Regulatory Ion in Immune Responses and Cell Behavior,"LENARDO, MICHAEL",NIH,,"$418,317"
